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1. LIST OF ABBREVIATIONS 
 
ANOVA  analysis of variance 
AP-1   activator protein 1 
bp   base pair(s) 
BSA   bovine serum albumin 
cAMP   cyclic adenosine monophosphate 
CBP   CREB-binding protein 
cDNA   complementary deoxyribonucleic acid 
cD2   chicken type 2 deiodinase 
CpG   cytidine-phosphateguanosine 
CREB   cAMP response element binding protein 
cRNA   complementary ribonucleic acid 
CSF   cerebrospinal fluid 
D1   type 1 deiodinase 
D2   type 2 deiodinase 
D3   type 3 deiodinase 
DBD   DNA binding domain 
DIG   digoxigenin 
DMEM  Dulbecco’s Modified Eagle Medium 
DNA   deoxyribonucleic acid 
DRIP/TRAP vitamin D receptor interacting protein/thyroid receptor associated 
protein 
DTT   dithiothreitol 
E   embryonic day, day of incubation 
EDTA   ethylenediaminetetraacetic acid 
EFsec   selenocysteine specific elongation factor 
ER   estrogen receptor 
FBS   fetal bovine serum 
fmol   femtomole(s) 
FSH   follicle stimulating hormone 
GFAP   glial fibrillary acidic protein 
HAT   histone acetyltransferase 
HDAC   histone deacetylase 
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HPT   hypothalamo-pituitary-thyroid 
HRE   hormone response element 
kb   kilobase(s) 
Km   Michaelis-Menten constant 
LBD   ligand binding domain 
LH   luteinizing hormone 
MCT   monocarboxylate anion transporter  
µl   microliter 
µM   micromole(s), micromolar 
mRNA  messenger ribonucleic acid 
mTRα   mouse thyroid receptor α 
NCoR   nuclear receptor co-repressor 
NGF   nerve growth factor 
NLS   nuclear localization signal 
nM   nanomole, nanomolar 
nTRE   negative thyroid response element 
OATP1C1  organic anion transporting polypeptides 1 
PBS   phosphate buffered saline 
PCAF   p300/CBP associated factor 
PCR   polymerase chain reaction 
PTU   propyl thiouracil 
PVN   paraventricular nucleus 
RNA   ribonucleic acid 
rT3   reverse T3, 3,3’,5’-triiodothyronine 
RTH   resistance to thyroid hormone 
RT-PCR  reverse-transcription-polymerase chain reaction 
RXR   retinoid X receptor 
SBP   selenocysteine binding protein 
SEAP   secretory alkaline phosphatase 
SEM   standard error of the mean 
SECIS   selenocysteine inserting sequence 
SMRT   silencing mediator of retinoid and thyroid receptors 
sORF   short open reading frame 
SRC   steroid receptor co-activator 
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SSC   standard sodium citrate 
SUN-CoR  small ubiquitous nuclear co-repressor 
SV   simian virus 
T2   diiodothyronine 
T3   triiodothyronine, 3,5,3’-triiodothyronine 
T4   thyroxine, 3,5,3’,5-tetraiodothyronine 
TBP   TATA-binding protein 
TH   thyroid hormone 
TK   thymidine kinase 
TRE   thyroid hormone response element 
TRH   thyrotropin releasing hormone 
TRα   thyroid receptor α 
TRβ   thyroid receptor β 
tRNA   transfer ribonucleic acid 
TSH   thyroid stimulating hormone, thyrotropin 
UTR   untranslated region  
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2. INTRODUCTION 
Thyroid hormone (TH) plays a fundamental role in the development and function of 
various organ systems. TH is especially important for the development and function of 
the brain (Bernal et al., 2003). Thyroxine (T4) is the most abundant (~80%) secretory 
product of the human thyroid gland. However, the presence of 3,5,3’-triiodothyronine 
(T3) was also revealed in the human plasma by Gross and Pitt-Rivers (1952). T3 is a 
deiodinated form of T4 and it was established that T3 is the compound responsible for 
most known TH-dependent biological effects despite its less than 20% presence in the 
thyroidal secretory output. Importantly, the existence of T4 to T3 conversion was proved 
by Sterling et al. (1976) indicating that not only the thyroid but also the prohormone T4 
can give rise to T3. 
The regulation of circulating TH levels is governed by the hypothalamo-pituitary-
thyroid (HPT) axis (Fekete and Lechan 2014). The HPT axis is programmed to keep 
serum T3 levels in the physiological range that is predominantly achieved by controlling 
the release of TH from the thyroid gland, especially via regulating the output of the 
long-lived T4 prohormone. However, TH action occurs in tissue/cell compartments and 
its regulation requires quick and tissue-specific costumization (Gereben et al., 2015). 
Thus, the impact of the HPT axis on tissue TH levels is limited. According to the 
current consensus, a complex and tissue-specific regulatory system is responsible for 
the control of tissue TH action. The crucial players of this system are the members of 
the deiodinase enzyme family that catalyze TH activation and inactivation, the TH 
transporters, and the nuclear machinery of TH action (Gereben et al., 2008; Visser 
2000). 
 
2.1. Thyroid hormones are crucial factors of development 
TH is essential for the development and differentiation of various cell types and exerts a 
striking impact on the developing central nervous system. A classical study established 
the correlation between iodine deficiency and cretinism (Ord 1888). It is well-known 
that congenital hypothyroidism is accompanied with detrimental effects. Therefore 
serum thyroid stimulating hormone (TSH) levels are subjected to routine screening in 
human neonates to ensure that TH supplementation will be performed in the critical 
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time window after birth to avoid the devastating and irreversible consequences (Fisher 
et al., 1979). 
It took decades to accumulate data allowing a deeper understanding of the underlying 
mechanisms. TH was found to be crucial in the regulation of later neuron differentiation 
events: proper myelination (Balázs et al., 1969a and 1969b), dendrit and axon 
development and synaptogenesis. It was also demonstrated that suboptimal TH levels 
affect the expression of genes controlling myelin formation in rats, e.g. the ones 
encoding myelin basic protein, proteolipid protein and myelin associated glycoprotein 
(Farsetti et al., 1991; Rodriguez-Pena et al., 1993). Under prolonged hypothyroidism, 
the number of myelinated axons decreased and axons of lower diameter were found to 
be not myelinated in neonatal rats. These changes were also observed in cortical regions 
involved in visual, auditory and motoric activities. THs are inevitable for proper cell 
migration and formation of the layers of the cerebral cortex. Purkinje cells in the 
cerebellum and the pyramidal cells in the cortex were found highly sensitive to 
appropriate TH availability. Purkinje cells are unable to develop their dentritic tree in 
hypothyroidism (Legrand 1967a and 1967b) and this was underlain by affected 
cytoskeletal organization (Silva and Rudas, 1990) while the late migration of granular 
cells in the cerebellum was also severely affected. THs also affect glial cell 
differentiation (oligodendrocytes, astrocytes and microglia) (Gharami and Das 2000; 
Lima et al., 2001). The underlying mechanisms involve biochemical changes related to 
glucose-amino acid conversion, glutamine-dehidrogenase activity, decreased activity of 
oxidative enzymes (Balázs et al., 1971; Cocks et al., 1970) and also yet not fully 
revealed mechanisms governed by cell-cycle modulators such as cyclin D1, E2F-1 or 
p27 (Garcia-Silva et al., 2002). It was shown that the number of matured astrocytes and 
oligodendrocytes is reduced in the white matter tracts of hypothyroid rats (Schoonover 
et al., 2004; Martínez-Galán et al., 1997). Furthermore, THs also impact the 
development of the cytoskeleton via the upregulation of glial acidic fibrillary protein 
(GFAP) and F-actin, as demonstrated both in animal and cell culture models (Paul et al., 
1996). THs enhance the secretion of different extracellular matrix proteins like laminin 
and fibronectin via growth factor secretion (Trentin et al., 1995 and 2001). Importantly, 
nerve growth factor (NGF) secreted by astrocytes has a crucial role in the control of 
neurit growth (Lindsay 1979; Charrasse et al., 1992). The abovementioned effects of 
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TH on glia cells also impact neurons. The role of TH played in neural development is 
summarized in Figure 1. 
 
Figure 1. Role of thyroid hormones during different stages of brain development (based on 
Bernal 2015). 
 
2.2. The structure and function of the HPT axis 
The HPT axis is governed by hypophysiotropic thyrotropin releasing hormone (TRH) 
expressing neurons of the hypothalamic paraventricular nucleus (PVN). Axons of these 
neurons project to the external zone of the median eminence, located below the floor of 
the third ventricle where TRH is released from axon varicosities (Lechan and Fekete 
2006). TRH reaches the anterior pituitary via the portal system and binds to the 7 
transmembrane domain containing Gq/11 protein coupled TRH receptors of thyrotropes 
followed by the increase of thyrotropin (TSH) production and secretion. TSH is a 
glycoprotein that is formed by an -subunit consisting of 92 amino acids (Salvatore et 
al., 2011). This subunit is very similar to those of the follicule stimulating hormone 
(FSH) and luteinizing hormone (LH) (Gray 1988). In contrast, the 110-amino acid-long 
-subunit of TSH is specific for this molecule. TSH reaches the thyroid gland by the 
circulation and binds to the 7 transmembrane domain containing TSH receptors on 
thyrocytes. In contrast to the TRH receptor, the TSH receptor is coupled to Gs protein 
and acts via the activation of adenylate cyclase and consequently evokes cyclic 
adenosine monophosphate (cAMP) release. The capacity of a given amount of TSH to 
induce cAMP release is regulated by TSH bioactivity, a phenomenon dependent on 
TRH-promoted glycosylation of the TSH molecule (Salvatore et al., 2011). TSH 
promotes various steps of TH formation and release. These include the iodide uptake of 
the thyrocytes in the thyroid gland, synthesis and iodination of the thyroglobulin, 
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endocytosis of the colloid and activation of peroxidase. TSH is also able to increase the 
rate of cell division in the thyroid gland (Portulano et al., 2014). 
TH regulates the HPT axis by negative feedback. Increased serum T4 and T3 levels 
decrease TSH and TRH secretion, while a decrease of circulating TH stimulates the 
hypothalamus and the anterior pituitary to release TRH and TSH, respectively. 
Tanycytes of the mediobasal hypothalamus play a very important role in the feedback 
mechanism. These specialized glial cells are located in the floor and the ventrolateral 
walls of the third ventricle (Bruni 1974, Krisch et al., 1978). Numerous tanycyte 
processes, especially those of -tanycytes located in the floor of the third ventricle end 
in the median eminence and contact capillaries and axon terminals of neurosecretory 
neurons (Lechan and Fekete 2007). Importantly, the median eminence is located outside 
of the blood-brain barrier and its TH content originates both from local, tanycyte-
generated sources and from the periphery (Kakucska et al., 1992). TRH expression in 
the PVN of hypothyroid rats could be normalized with exogenous T3 only with a dose 
evoking hyperthyroidism in the periphery. This finding clearly underlines the functional 
importance of hypothalamic T4 to T3 activation in the regulation of TRH (Kakucska et 
al., 1992). Tanycytes are able to uptake T4 either from the fenestrated capillaries of the 
median eminence, the intercellular space of the basal hypothalamus or from the 
cerebrospinal fluid (CSF). They actively convert T4 to T3 since these cells contain high 
amounts of deiodinase type 2 (D2) enzyme (for more details of D2 see Section 2.3). The 
generated T3 is released either to the mediobasal hypothalamus, the CSF or the median 
eminence into the microenvironment located between tanycyte processes and axonal 
segments of parvocellular neurosecretory neurons. Hypophysiotropic TRH neurons 
contain monocarboxylate anion transporter 8 (MCT8) protein in the plasmamembrane 
of their axons that enables them to uptake T3 in the median eminence and consequently 
this allows the regulation of TRH expression by T3 of the median eminence (Kalló et al., 
2012). This could work via an anticipated retrograde axonal transport of T3 to reach the 
PVN but this remains to be proved. This is an important point to be revealed since TRH 
neurons in the PVN rely on external T3 due to their inability to generate T3 is underlain 
by the lack of D2 in these cells. Furthermore, a significant portion of TRH neurons do 
not contain the TH degrading deiodinase 3 enzyme (D3), thus their ability to actively 
regulate their intracellular T3 content is limited, indicating that these cells are 
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programmed to accurately translate the hypothalamic T3 levels into TRH expression 
(Kalló et al., 2012). Thus, in the mediobasal hypothalamus, D2-mediated local 
regulation of T3 availablity functionally interacts with the regulation of the HPT axis. 
See Figure 2 for summary. 
 
 
Figure 2. The hypothalamo-pituitary-thyroid axis and its interaction with local D2-mediated T3 
generation. TRH: thyrotropin releasing hormone, TSH: thyroid stimulating hormone, T4: 
thyroxine, T3: triiodothyronine, DIO1: deiodinase type 1, DIO2: deiodinase type 2 (modified 
from Gereben et al., 2015). 
 
While TH is a major regulator of hypophysiotropic TRH neurons, these cells also 
receive afferents from different brain regions to allow proper response of the axis to the 
changing environment. Metabolic signals are transmitted from the arcuate nucleus, 
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circadian signals come from the suprachiasmatic nucleus while catecholaminergic 
afferents from the brainstem transmit information on changes of the external 
temperature (Fekete and Lechan 2014). 
Set-point formation of negative feedback during ontogeny is a fundamental process for 
the regulation of the HPT axis and its consequences persist through the entire lifespan. 
However, only limited information is available on the onset of the negative feedback 
mechanism. 
Both the development of the brain and the ontogeny of the HPT axis show marked 
species-specific differences. Rats are altricial animals, their brain is not well developed 
at birth and their hypothalamo-pituitary-thyroidal gland axis is not fully matured 
(Schwartz 1983, Legrand 1986). In contrast, the precocious sheep (Fisher 1991) and 
chickens have well developed HPT axes at the date of birth or hatching (Oppenheimer 
and Schwartz, 1997). Children at birth represent an intermediate state between these 
examples with an immature central nervous system but a fully developed axis. Thus 
rodents do not serve as appropriate model for the regulation of the development of the 
human HPT axis while the related mechanisms of hypothalamic feedback cannot be 
studied in humans due to ethical reasons. Therefore, chickens represent an invaluable 
model for these studies, since the developmental kinetics of the chicken HPT axis is 
rather similar to that of humans. In addition, the chicken embryo allows to study 
developmental phenomena in the absence of interfering maternal regulatory circuits. In 
contrast, data obtained from rats should be handled with care because of the significant 
differences exisiting between the development of the HPT axes of rodents and humans 
(Taylor et al., 1990). 
In birds THs control piping, hatching, thermogenesis and growth, but also play a role in 
the neurulation of the chicken embryo (Flamant and Samarut 1998; Decuypere et al., 
1990; Beckett and Arthur 1994). The onset of the thyroid function in chickens starts 
from embryonic day 9.5 (E9.5), T4 and T3 can be detected in the yolk and serve as 
maternal thyroid hormone supply (Prati et al., 1992). The thyroid gland starts to secrete 
its hormones in increasing amounts, but the TSHβ mRNA is increasing further until E19 
as the negative feedback is not yet functional at this developmental stage (Gregory et 
al., 1998). 
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2.3. Regulation of tissue TH action by deiodination 
Many organs can customize their TH action independently from circulating TH levels 
and deiodinase enzymes play a striking role in this event (Gereben et al., 2008). 
Thyroxine can be activated by 5’ deiodination by removing iodine from the outer 
phenolic ring of thyroxine (activation pathway) while inner ring 5 deiodination results 
in the inactivation of T4 or T3 (Figure 3). Historically, the tissues were categorized 
based on their capability of utilizing TH. Tissues contributing to serum TH levels were 
considered as TH exporters while those tissues which do not, were considered as TH 
importers (Crantz et al., 1982). While this nomenclature properly recognized the 
importance of tissue-specific differences in TH economy, in light of recent data it falls 
short to address that i) tissue specific contribution to systemic TH levels is not constant 
but dependent on TH status and ii) in organs with complex cellular composition it also 
depends on cell-type specific events. For example, the rodent heart is not capable of 
producing T3 locally and it is fully dependent on the circulating T3 in the serum. The 
liver is TH importer in euthyroidism and TH exporter in hyperthyroidism. Importantly, 
the brain generates most of its T3 locally, but does not contribute significantly to the T3 
level of the serum. Furthermore, striking compartmentalization exists inside the brain, 
as the glial compartment performs T3 generation and the neuronal compartment 
consumes T3. Thus, cell-type specific events ensure the cellular export and import of 
TH within the same tissue (see Section 2.4). In humans, T3 originates predominantly 
from D2-mediated outer ring deiodination of the prohormone thyroxine in tissues (Maia 
et al., 2005). While biochemically both D2 and type 1 deiodinase (D1) can catalyse this 
process, due to its high Km, D1 is not capable of generating T3 under euthyroid 
conditions. Consequently, in vivo, D2 is the predominant activating deiodinase. 
These enzymes belong to the selenodeiodinase enzyme family and contain the rare 
amino acid selenocysteine in their active center. In the deiodinase encoding mRNA 
selenocysteine is encoded by an in-frame UGA codon that serves otherwise as a stop 
codon in proteins that do not belong to the selenoprotein family. The translational 
readthrough of UGA is ensured by a specific mRNA secondary structure, the 
selenocysteine inserting sequence (SECIS) element, located in the 3’ untranslated 
region (3’UTR) of the selenoprotein encoding mRNA (Berry et al., 1991a; Gereben et 
al., 1999). The SECIS binds the SECIS binding protein (SBP2) that interacts with 
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selenocysteine specific elongation factor (EFSec). The latter binds selenocysteine 
transfer RNA (tRNA) allowing cotranslational selenocysteine incorporation at the UGA 
on the ribosome (Bianco et al., 2002). Although this process is very complex and energy 
consuming, the resulting selenocysteine-containing deiodinase enzyme has much higher 
substrate affinity than the cysteine-containing version. This is because selenium can be 
ionized more easily at physiological pH than the sulphur of cysteine, turning the formed 
protein into a much more powerful oxido-reductase. On the other hand, this comes to 
the cost of the efficiency of translation that is ~50-100 times lower for the 
selenodeiodinase D2 than for its cysteine mutant version (Steinsapir et al.; 2000). 
Therefore, selenocysteine incorporation results in a low level of selenoenzyme that is 
highly efficient (Berry et al., 1991b). 
D1 is capable of removing the iodine from both the outer and inner rings, while D2 is an 
exclusive outer ring deiodinase. An important difference between the two enzymes is 
that the in vitro Km of D1 for T4 deiodination is much higher (1-2 µM) compared to D2 
(1-2 nM). D1 has low affinity and high capacity, at the same time D2 has high affinity 
and low capacity for T4. While D1-mediated deiodination is strongly inhibited by 6n-
propyl-thiouracil (PTU), D2 deiodination is not. This feature helped to discover the 
PTU-resistant 5’ deiodination and as a consequence to identify D2 in the pituitary of 
hypothyroid rats (Silva and Larsen, 1977). D2 is the enzyme that can efficiently 
generate T3 in vivo, while D1-mediated T3 generation can only occur under 
hyperthyroid conditions. Although D1 predominantly inactivates reverse T3 in vivo, the 
special kinetics of D2 enables this protein to activate thyroxine even at low substrate 
levels. 
D1 was identified in several tissues. In rats liver, kidney, thyroid gland and the pituitary 
contain D1. Its 2.1 kb long cDNA was cloned by Berry et al. (1991a). D1 is anchored to 
the plasmamembrane (Baqui et al., 2000). 
D2 is present in the glial compartment of various brain regions and in the pituitary 
(Silva and Larsen, 1977). It can also be found in brown adipose tissue, placenta, 
keratinocytes, myocardium, skeletal muscle and in the thyroid gland (Salvatore et al., 
1996b; Croteau et al., 1996, Bianco et al., 2002). The first full length D2 cDNA of 
higher vertebrates was isolated from chicken (Gereben et al., 1999). The D2 mRNA 
DOI:10.14753/SE.2017.2032
 15 
 
contains a SECIS element close to the end of 3’UTR. The coding region is of average 
size (840 bp) but the whole RNA is unusually long (6094 bp) due to the long 
untranslated regions and the distance between the SECIS and the UGA of the active 
center is almost 5 kb. D2 is localized in the endoplasmic reticulum (Gereben et al., 
2008). 
D3 represents the third known member of the family. This enzyme removes iodine from 
the inner ring of TH and its main role is to inactivate T4 and T3. D3 is expressed in the 
brain, palcenta, skin and fetal liver. D3-mediated T3 inactivation is crucial in the 
regulation of TH availability in neurons and also prevents the fetus from high levels of 
maternal T3 in specific phases of ontogeny (Tu et al., 1999; Gereben et al., 2008). D3 is 
localized in the plasmamembrane and in the dense core vesicles of neurosecretory 
neurons (Baqui et al., 2003; Kalló et al., 2012). 
 
Figure 3. Deiodinase-mediated metabolism of iodothyronines. T4: thyroxine, T3: 
triiodothyronine, T2: diiodothyronine, reverse T3: reverse triiodothyronine (Gereben et al., 
2008). 
 
2.4. Regulation of thyroid hormone availability in the brain 
T4 and T3 concentrations in the brain are strictly governed by complex, locally 
controlled mechanisms. This process is tightly regulated by deiodination-dependent TH 
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metabolism and neuro-glial TH transport (Freitas et al., 2010; Gereben et al., 2008). It 
was demonstrated that in the brain of rat fetuses T3 is exclusively generated from local 
T4 deiodination and the circulating T3 virtually does not reach the brain and a high 
proportion of T3 (>80% in the cerebral cortex) was shown to be locally generated in the 
adult rat brain (Crantz et al., 1982). As it was discussed in details in Section 2.2, the 
median eminence is a unique region of the brain which lies outside of the blood-brain 
barrier, so T3 from the periphery can reach this area. In contrast, other tissues like the 
liver are readily accessed by serum T3 (Calvo et al., 1990; Grijota-Martinez et al., 2011). 
Due to the presence of D3 in the axonal compartment of the external zone of the median 
eminence, T3 availability is subjected to cell-type specific regulation in this crucial 
sensor region (Kalló et al., 2012). 
In the brain, D2 and D3 are responsible for the regulation of TH availability. D2 is 
expressed in astrocytes in various brain regions and in tanycytes located in the floor and 
infralateral wall of the mediobasal hypothalamus (Tu et al., 1997). In contrast, D3 is 
expressed in neurons (Tu et al., 1999). Astrocytes generate T3 from the T4 by taking it 
up from the brain capillaries and provide activated TH to neurons (Freitas et al., 2010). 
This cell compartment regulates its intracellular TH levels via D3-mediated degradation 
of T4 to rT3 and T3 to and T2. 
As it was discussed in details in Section 2.2, the highest D2 expression in the brain can 
be found in the tanycytes and this phenomenon has a crucial role in the feedback 
regulation of the hypophysiotropic TRH neurons. Cell-type specific ablation of D2 
activity in astrocytes and in the pituitary of transgenic mice revealed that the astrocytic 
D2 pool exerts no impact on the regulation of the HPT axis. It also shed light on the 
complex functional interactions allowing the hypothalamus to keep the systemic TH 
economy in balance even in the absence of pituitary D2 (Werneck de Castro et al., 
2015). Perivascular glial cells take up thyroxine from the blood vessels while a smaller 
fraction of TH is transported through the choroid plexus and the cerebrospinal fluid. TH 
passes the plasmamembrane via membrane transporters like the monocarboxylate anion 
transporter 8 and 10 and the natrium independent organic anion transporting 
polypeptides 1 (OATP1C1). MCT8 transporters are specific to iodothyronines and 
transport both T3 and T4. The transporter is expressed in the blood-brain barrier, choroid 
plexus, neurons, tanycytes and astrocytes (Heuer et al., 2005). OATP1C1 transports 
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mainly T4 and it can be found in the endothelial cells of the blood-brain barrier and 
choroid plexus and in the astrocytes (Roberts et al., 2008). L-type amino acid 
transporters were also described in the astrocytes and neurons (Jansen et al., 2005). 
Mutations in the MCT8 transporter protein are manifested in an X chromosome-linked 
psychomotor retardation, the Allan-Herndon-Dudley syndrome that is hallmarked in 
neonates by neurological symptoms, global developmental delay and mental deficiency 
due to the defects in the T3 transport in critical development phases (Bernal 2005). 
However, MCT8-deficient mice show only negligible neurological impairments (Liao et 
al., 2011). This is underlined by a compensatory effect of OATP1C1 that was elegantly 
demonstrated by the severe phenotype of the double MCT8/OATP1C1 double knock-
out (Mayerl et al., 2014). In parallel, it was demonstrated that the level of the OATP1C1 
transporter is much lower in humans compared to rodents allowing less compensation 
for MCT8 deficiencies (Heuer et al., 2005). 
 
2.5. Machinery of nuclear thyroid hormone action: thyroid hormone receptors 
and thyroid hormone response elements 
In principle, hormones act in two different ways on their target cells: a group of 
hormones (polypeptides, monoamines, prostaglandins) do not enter the cells and bind to 
receptors on the cell surface, while another large group of hormones (small lipophilic 
molecules) enter the target cells and display their effects through intracellular receptors 
(Lazar 2011). TH receptors (TRs) belong to the nuclear hormone receptor superfamily 
and represent the cellular homologues of the v-erbA oncogen of the avian 
erythroblastosis retrovirus (Weinberger et al., 1986; Sap et al., 1986). Other members of 
this superfamily are receptors of  
 other classical hormones (e.g.: glucocorticoid, mineralocorticoid, estrogen, 
androgen) 
 vitamins (vitamin D, retinoic acid, retinoic X) 
 metabolic intermediates and products (that ligand peroxisome proliferator-
activated, liver X, bile acid receptor, Rev-Erb receptor) 
 xenobiotics (that ligand pregnane X and constitutive androstane receptor) 
(Mangelsdorf et al., 1995) 
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Orphan receptors with unknown ligand were also described. A good example of this is 
the Rev-erb A receptor (Yen 2001). 
The nuclear hormone receptors are hormone dependent transcription factors having a 
molecular weight in the range of ~100 kDa. For nuclear trafficking, a nuclear 
localization signal (NLS) is required to be attached to the receptor upon translation 
(Lazar 2011). Members of the nuclear receptor superfamily share a similar domain 
structure and contain separated domains for DNA binding and ligand binding (see 
Figure 4). The DNA binding domain (DBD) and the ligand binding domain (LBD) are 
located at the amino and carboxy-terminal portion of the protein, respectively. Despite 
the structural similarity of this domain (with 12 α helical segment), slight molecular 
differences in the region account for the ligand specificity. The DNA binding domain is 
able to recognize specific DNA sequences (hormone response elements, HREs) in the 
promoter region of a responsive target gene. The DBD contains zinc fingers that contact 
the DNA, the region responsible for the recognition of the specific DNA hexamer is the 
P box that is basically a small stretch of amino acids (Lazar 2011). TR binds the 
AGGTCA hexamer, also called as half-sites (see Figure 5), while glucocorticoide 
receptors bind to AGAACA. In some cases the receptor binds to extended half sites 
with C-terminal extension of the DNA-binding domain. TR predominantly binds the 
DNA heterodimerized with Retinoid X receptor (RXR). The dimers bind to the two half 
sites and the number of bases and the sequence between the half sites determine the 
target gene specificity. TRs usually bind to direct repeats separated by 4 bases between 
them (Umesono et al., 1991), but in some cases the orientation of the half-sites and their 
spacing is different (Williams and Brent 1995). RXR and TR bind to the 5’ and 3’ half 
site sequences, respectively. Upon ligand binding, TR undergoes a conformational 
change which alters its capacity to recruit coactivators or corepressors. This event is a 
prerequisite of the TR-dependent alteration of gene transcription. Whether the resulting 
effect will be manifested in activation or repression is primarily dependent on the TRE 
characteristics of a specific gene (see Section 2.6). 
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*nuclear localisation signal 
Figure 4. General structure and functions of the nuclear receptors 
 
 
Figure 5. Binding of thyroid hormone receptors to DNA. Thyroid (TR) and retinoid X receptor 
(RXR) heterodimers bind to DNA half site sequences called TH response element (TRE). 
 
2.5.1. Thyroid hormone receptor isoforms 
Two TR isoforms have been identified. TRα was first isolated from chicken liver (Sap 
et al., 1986) and at the same time also from rat brain (Thompson et al., 1987). The TRβ 
was isolated from human placenta (Weinberger et al., 1986), chicken (Forrest et al., 
1990 and 1991) and rat (Obregon et al., 1986). TRα and TRβ are encoded by two 
separate genes: TRα on the human chromosome 17, while TRβ on chromosome 3. TRα 
has two main subtypes, α1 and α2. TRα2 is an alternatively spliced variant, which is 
unable to bind thyroid hormones because some critical amino acids are replaced in the 
carboxy-terminal (Lazar et al., 1989b) and the dimerization properties of this receptor 
isoform are also changed. Some further protein products encoded by the TRα gene were 
also described such as TRα3 and the truncated ΔTRα1 and ΔTRα2 proteins. The 
function of the isoforms that do not bind the hormone is not clear, although these might 
have a role in attenuating the physiological effects of T3 by competing with the T3 
binding variants (Lazar et al., 1989a). 
The TRβ gene encodes four different types of proteins: TRβ1, TRβ2, TRβ3 and ΔTRβ3. 
All of them are able to bind T3 but the truncated ΔTRβ3variant cannot bind to the DNA. 
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The A and B domains of the TRβ receptors are different from each other but their DNA 
and ligand binding domains are very similar. 
The tissue distribution of TR isoforms shows tissue-specific differences and their 
physiologic role depends on the given tissue in which they are expressed. It was e.g. 
demonstrated that TRα is important in the regulation of cardiac function, body 
temperature, intestinal and lymphocyte development. This receptor is also widely 
expressed in the brain (Morte et al., 2002). Some studies in mice confirmed the role of 
TRα in behaviour as it is responsible for the specification of the hippocampal neural 
circuits (Guadano-Ferraz et al., 2003). TRβ can be found in the pituitary, liver and 
cochlea. TRβ2 is the predominant TR isoform in the PVN (Bernal et al., 2003; Abel et 
al, 2001) and this subtype is responsible for the differentiation of the Purkinje cells in 
the cerebellum. For the different receptor types and their functions see Table 1. 
Table 1. Thyroid hormone receptor isoforms, their tissue distribution and functions 
 
 (Based on Ortiga-Carvalho et al., 2014) 
TRs are expressed in humans and in sheep well before the formation of the thyroid 
gland and the onset of thyroid hormone synthesis. In the human fetus the receptors can 
be detected from the 10
th
 week of gestation while in sheep from the 50
th
 day. TRα1 
isoform is responsible for the vast majority of the total T3 binding in the fetal brain 
(Schwartz et al., 1992; Strait et al., 1991). In the adult rat brain distribution of T3 
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binding in the brain is approximately 60% α1, 30% β1 and 10% β2 (Schwartz et al., 
1994). 
Several types of thyroid hormone receptor mutations were described and TR knockout 
murine models provided novel insights into the physiological roles of the different 
receptor types (Ortiga-Carvalho et al., 2014). It was shown in mice that in the absence 
of TRβ neither behavioural nor neuroanatomical abnormalities were observed (Forrest 
et al., 1996b). The TRβ knockout mice are deaf, their colour vision is impaired 
indicating the role of this receptor type in the development of the cochlear cell and the 
retinal photoreceptor. Human patients without TRβ have normal mental development 
(Takeda et al., 1992), but the cochleo-vestibular development may be affected (Forrest 
et al., 1996a; Refetoff et al., 1967). Resistance to thyroid hormone syndrome (RTH) is 
typically caused by mutations in the TRβ gene (Jones et al., 2003). Patients with 
mutated TRβ have severe learning difficulties and reduced intelligence quotient. Their 
TSH and thyroid hormone levels are increased, goitre is developed accompanied with 
an impaired negative feedback of the HPT axis. The vision and hearing of these patients 
are also affected and heart defects, such as tachycardia, exacerbate the homeostatic 
functions (Refetoff and Dumitrescu 2007, Pazos-Moura et al., 2000). In general, 
mutations in TRβ manifest in more severe clinical signs than the complete absence of 
the receptor. 
More recently, TRα1 mutant RTH patients have also been identified without presenting 
major disturbances in parameters of TH economy; in these cases TSH and circulating 
thyroid hormones are only mildly affected. On the other hand, the syndrome is 
represented by growth retardation, delayed bone development, cognitive deficits, severe 
constipation and impaired neuronal development (Van Mullem et al., 2012; Vennström 
et al., 2008). 
It needs to be mentioned that the lack of TR function and hypothyroidism are 
manifested in different consequences since the deletion of TRs in knock-out mice do not 
lead to brain hypothyroidism. This is supported by the fact that the unliganded TRs can 
also act on their target gene, either in a positive or a negative manner, depending on the 
positive or negative regulation of the gene by T3. This removal of TR function also 
abolishes the regulatory function of unliganded TRs (Chassande 2003). 
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2.6. Assessment of thyroid hormone action 
Binding of TH to TR exerts either activating or repressory effect on TH responsive 
target genes (Glass and Rosenfeld 2000). 
2.6.1. Positive regulation of gene expression by thyroid hormones 
In contrast to the other nuclear homone receptors, e.g. the estrogen receptor (ER), the 
TR-RXR heterodimers are predominantly located in the nucleus even in the absence of 
ligand and even the unliganded TR can bind to TRE. Under uninduced conditions of a 
positively regulated TH sensitive gene the TR/RXR heterodimers bind co-repressor 
molecules. Binding of T3 triggers a conformational change of TR that will release co-
repressors and bind co-activators. This TH-mediated activation of a positively regulated 
gene consists of derepression followed by activation. See Figure 6 for a schematic 
depiction of positively regulated genes (Lazar 2003). 
 
 
Figure 6. Activation and repression of positively regulated genes by thyroid hormone receptors. 
(Based on the model described by Lazar, 2003). (RXR: retinoid X receptor, TR: thyroid 
hormone receptor, CoR: co-repressor, CoA: co-activator, TRE: thyroid hormone response 
element, TH: thyroid hormone). 
 
Several co-activators were identified that enhance the transcriptional activation of TH-
responsive genes after TR binds to its ligand. Two important members of TH co-
activators are the steroid receptor co-activator complex (SRC) and the vitamin D 
receptor interacting protein/thyroid receptor associated protein complex (DRIP/TRAP 
complex). SRCs have three subtypes: SRC-1, SRC-2 and SRC-3. Beside their capability 
to associate with TR they can also interact both with the CREB-binding protein (CBP) 
and p300. The CBP/p300 complex is able to interact with p300/CBP associated factor 
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(PCAF) that possesses histon acetylase (HAT) activity. Histon acetylases promote 
loosening the chromatin structure allowing transcription of the TH-responsive gene 
(McKenna et al., 1999). PCAF and CBP are able to interact with TATA-binding protein 
(TBP) associated factors and RNA polymerase II. Co-activators are able to bind to the 
helices 3, 5 and 6 of the ligand binding pocket of TR with their consensus LXXLL 
amino acid sequence. The components of the DRIP/TRAP pathway are able to associate 
with RNA polymerase II but they do not possess histone acetylase activity. 
Major co-repressors of TH action are represented by the nuclear receptor co-repressor 
(N-CoR) and the silencing mediator of retinoid and thyroid receptors (SMRT). The 
latter is capable of anchoring further large multiprotein complexes that contain histon 
deacetylase (HDAC) activity. Histon deacetylases play a crucial role in maintaining the 
chromatin structure in a form that does not favour the basal transcription. DNA 
methylation may also attribute to basal repression since methyl-CpG-binding proteins 
associate with Sin3 containing co-repressor complex and HDAC (Nan X et al., 1998; 
Wade et al., 1999). Small ubiquitous nuclear co-repressor (SUN-CoR) was also 
described (Zamir et al., 1997). The nuclear receptor co-repressor (NCoR) and the 
SMRT are approximately 50% homologue based on their amino acids and have similar 
structural domains. In the interaction domain of NCoR and SMRT consensus sequences 
(I/L)xx(I/V)I were found, similarly to that of the co-activators described above (Lazar 
2011). 
2.6.2. Negative regulation of gene expression by TH 
Mechanisms underlying TH-dependent negative regulation of gene expression are still 
incompletely resolved and different models have been worked out to explain the 
phenomenon. According to one of these models, TR binds to a negative TRE (nTRE). It 
means that in the case of hormone binding the receptor anchors to co-repressors (with 
HDAC activity), on the other hand in unliganded state the receptor binds to co-
activators (with HAT activity). One of the in vivo examples for this model is 
represented by the negative effect of the TH bound receptor on TSH expression in the 
pituitary (Shibusawa et al., 2003) and on the regulation of TRH (see Figure 7). 
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Figure 7. Activation and repression of negatively regulated genes by thyroid hormone receptors 
(Model 1). (Based on the model described by Shibusawa et al., 2003) (RXR: retinoid X 
receptor, TR: thyroid hormone receptor, CoR: co-repressor, CoA: co-activator, nTRE: negative 
thyroid hormone response element, TH: thyroid hormone). 
 
It was also suggested that on negatively regulated target genes co-repressor complexes 
are recruited in the absence of TH. After T3 binding co-activators are recruited, but at 
the same time the transcription is repressed (Astapova and Hollenberg 2013) (Figure 8). 
 
 
Figure 8. Activation and repression of negatively regulated genes by thyroid hormone receptors 
(Model 2). (Based on the model described by Astapova and Hollenberg 2013). (RXR: retinoid 
X receptor, TR: thyroid hormone receptor, CoR: co-repressor, CoA: co-activator, TRE: negative 
thyroid hormone response element, TH: thyroid hormone). 
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It was also suggested, that TR binding to DNA is not a prerequisite of the TH-mediated 
negative regulation (Zhang et al., 1991; Pfahl 1993). In this case, an activator protein 1 
(AP-1) heterodimer (consisting of Jun and Fos) is involved in the process. Upon AP-1 
binding TR recruits co-activators in the absence of the ligand and binds to co-repressor 
if T3 is present (Figure 9). 
 
 
Figure 9. Activation and repression of negatively regulated genes by thyroid hormone receptors 
(Model 3). (Based on the model described by Zhang et al., 1991 and Pfahl, 1993). (RXR: 
retinoid X receptor, TR: thyroid hormone receptor, CoR: co-repressor, CoA: co-activator, AP-1 
site: activator protein 1 binding site, TH: thyroid hormone). 
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This model can also involve regulation by non-T3 dependent pathways, indicating that 
TR can compete with other nuclear receptors for co-activators or co-repressors (Figure 
10). Without the ligand they bind (“steal”) co-repressors, while in the presence of TH 
they bind to co-activators (Kamei et al., 1996 and Tagami et al., 1997). 
 
 
Figure 10. Activation and repression of negatively regulated genes by thyroid hormone 
receptors (Model 4) (Based on the model described by Kamei et al., 1996 and Tagami et al., 
1997). (RXR: retinoid X receptor, TR: thyroid hormone receptor, CoR: co-repressor, CoA: co-
activator, AP-1 site: activator protein 1 binding site, TH: thyroid hormone, GR: glucocorticoid 
receptor). 
 
2.7. Posttranscriptional mechanisms regulating biological activity 
2.7.1. Alternative splicing 
Alternative splicing is a phenomenon in eukaryotes which increases the biodiversity of 
proteins encoded by the genome (Black 2003). Precursor messenger RNAs (or primary 
transcripts) can be modified by post-transcriptional processes. Alternative splicing can 
generate different mRNAs and as a consequence, different protein subtypes can be 
encoded by the same gene. There are two distinct mechanisms of alternative splicing, 
the exon skipping/switching and the intron slippage (Habener 2011). During exon 
skipping some exons are included while some of them may be excluded from the 
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primary transcript. Intron slippage is a process in which part of an intron is used in an 
exon, thus part of the intron becomes a coding region. Various examples are known 
when alternative splicing affects TH signaling. As it has been already highlighted in 
Section 2.5.1 the TRα2 is an alternatively spliced variant of the TRα1 isoform which is 
not able to bind T3 (Lazar et al., 1989b). 
2.7.2. The 5’ untranslated region of the D2 mRNA 
The 5’ untranslated region (5’UTR) of a specific mRNA is located between the 5’ 
proximity of the mRNA and the translational initiator ATG of the protein encoding 
region. The 5’UTR of the chicken D2 mRNA is unususally long (~600 bp). It contains 
short open reading frames (sORF) (Gereben et al., 1999). The sORFs are small 
alternative coding regions flanked by start and stop codons separated by an RNA 
segment consisting of bases in a number divisible by 3. Presence of the “Kozak 
consensus sequence” is the prerequisite of an efficient translational initiation of an 
eukaryotic open reading frame, represented by purine nucleotides (adenine or guanine) 
in the -3 position, where +1 is the first base of the ATG start codon (Kozak 1986). 
According to the scanning model of translation, the 40S ribosomal subunit moves 5’ to 
3’ along the mRNA and upon reaching an ATG embedded into a Kozak consensus gets 
charged with methionine and by the help of additional factors recruits the 60S subunit in 
order to initiate translation (Alberts et al., 1994). Thus, sORFs in the 5’UTR of D2 may 
be subjected to translation. 
 
2.8. Measurement of TH-dependent gene expression with promoter assays 
2.8.1. Luciferase assays in general 
Accurate measurement of gene transcription is a critically important tool to study 
genomic events underlying modulation of cell function. This is especially important for 
studies on TH-mediated events since most of the known effects of this hormone involve 
TH-induced transcriptional events. Taking advantage of bioluminescence is a state of 
the art approach to study transcriptional events. Bioluminescence, by definition, is the 
production and emission of visible light by a living organism as a result of a natural 
chemical reaction (McElroy et al., 1969). Several organisms are capable of producing 
light such as bacteria, insects, fungi and different marine organisms. During the 
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chemical reaction, the photon emitting luciferin gets oxidized by the luciferases. 
Luciferins are conserved but the luciferase enzymes are species-specific. The best 
established firefly luciferase originates from the North American firefly Photinus 
pyralis and is a 61 kDa protein. Renilla luciferase originating from Renilla reniformis 
represents another luciferase protein which was isolated from corals of coastal waters of 
North America (Lorenz et al., 1991). Recently, a novel luciferase enzyme Nano 
luciferase has been isolated from deep sea shrimp Oplophorus gracilirostris. It contains 
two smaller 19kDa and two larger 35 kDa subunits. This luciferase was used to develop 
the engineered luciferase NanoLuc in which the furimazine is used as a coelenterazine 
analogue. For cellular analytical assays this new luciferase has the advantage that it is 
more stable, showing brighter luminescence with sustained signal duration, has greater 
thermal, pH and urea stability, smaller size (19kDa) and monomeric structure. Its 
emission maximum is at 460 nm (Hall et al., 2012). Luciferase assays are rapid, 
sensitive and require non-radioactive substrates. In general, they are approximately 30-
1000 times more sensitive than the classical chloramphenicol acetyltransferase reporter 
system (de Wet et al., 1987). It was also confirmed that luciferin is able to enter the cells 
enabling to conduct the luciferase expression studies in intact cells. 
2.8.2. Investigation of thyroid hormone response elements 
It is a crucial requirement of accurate gene expression studies that the reporter itself 
should not be affected by the factor used to modulate the promoter and its flanking 
region. However, in CV1 mammalian cells expression of the classical firefly luciferase 
was down-regulated by T3 in a TR-dependent but promoter-independent manner 
(Tillman et al., 1993). Consequently, the CV1 cells cannot be reliably used for TRE 
structure or activity studies. This phenomenon was further evaluated with the analysis 
of unliganded thyroid hormone receptors on the Luc expression in HEK-293, COS-7 
and JEG-3 cells (Maia et al., 1996). Among these cell lines the choriocarcinoma cell 
line JEG-3 was found to be the most sensitive for these studies. The authors suggested 
that an unidentified negative TRE should be present in the luciferase coding region and 
concluded that firefly luciferase cannot accurately measure the T3-dependent gene 
expression. 
Later, a cautionary note has been issued by Chan et al. (2008) regarding the use of the 
pBi-L (Clontech, Mountain View, CA, USA) dual expression plasmid for the generation 
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of transgenic mice. In these studies the expression of both TRα1 and luciferase were 
negatively regulated by T3. This was independent of both the cis introduction of TR in 
the vector and the trans expression of TR from another vector. The negative regulation 
could be observed only in the presence of TRs and only in those vectors that contained 
the luciferase reporter. All these data above demonstrate that the use of firefly luciferase 
has its limitations in the T3-dependent gene expression studies. 
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3. OBJECTIVES 
 
Regulatory factors of thyroid hormone mediated effects were studied using 
molecular and cell biological approaches. We focused on the following issues. 
 
I. Investigation of thyroid homone availability in the developing chicken 
hypothalamus 
II. Understanding the RNA-dependent post-transcriptional regulation of the type 2 
deiodinase (D2) encoding dio2 gene 
III. Identification of authentic reporter proteins for studies on T3-dependent gene 
transcription 
 
We intended to address the following specific questions: 
1. What is the distribution pattern of the D2 mRNA in the developing and adult 
chicken brain? 
2. Do alternative splicing and the D2 5’UTR play a role in the post-
transcriptional regulation of D2 activity? 
3. Are novel luciferase reporters more accurate to assess T3-mediated 
transcriptional changes than the classical firefly luciferase? 
  
DOI:10.14753/SE.2017.2032
 31 
 
4. METHODS 
4.1. Animals 
Eight-week-old specific pathogen-free White Leghorn chickens and chicken embryos 
on the embryonic day (E)7, E8, E9, E10, E11, E13, E15 and E17 were obtained from 
the Central Veterinary Institute and Ceva-Phylaxia (Budapest, Hungary). The 
incubation was started at E0. Animal tissue samples were collected in accordance with 
the legal requirements of the Animal Care and Use Committee of the Institute of 
Experimental Medicine (Hungarian Academy of Sciences, Budapest). 
 
4.2. Generation of expression constructs 
4.2.1. Constructs prepared for the analysis of RNA-dependent post-transciptional 
regulation of D2 
The backbone of the chicken D2 (cD2) reporter construct contained a cD2 coding 
region between EcorI-HindIII and a rat D1 minimal SECIS element between HindIII-
NotI (Gereben et al., 1999). Constructs were prepared with different UTR fragments 
cloned between the SacII site of the D10 vector and EcoRI. To generate the cD2 5’UTR 
construct, SacII-EcoRI fragment of the full-length cD2 cDNA was inserted between the 
corresponding sites of the cD2 reporter. The cORF(Wt)-cD2 construct was prepared by 
using oligonucleotides: sense tccccgcggG CCGAGAAACA ATGGGATAGC 
GCgaattcc and antisense, ggaattcGCG CTATCCCATT GTTTCTCGGC ccgcgggga. 
Oligonucleotides were annealed to generate double stranded DNA. For the cORF(Mut-
ATG)-cD2 construct, the following oligonucleotides were used for annealing (sense, 
tccccgcggG CCGAGAAACA tTGGGATAGC Gcgaattcc; antisense, ggaattcGCG 
CTATCCCAaT GTTTCTCGGC ccgcgggga). The resulting inserts were cloned after 
SacII-EcoRI digestion into the cD2 reporter. The cDNA encoding the Δ77cD2 protein 
was isolated as described in Section 4.4. The spliced cDNA was inserted between SacII 
and NotI of the D10 mammalian expression vector using the same approach as 
described before for the wild-type cD2 mRNA (Gereben et al., 1999). The generated 
constructs were confirmed by automated sequencing. 
4.2.2. Generation of expression constructs for the analysis of luciferase reporters  
The thymidine kinase-luciferase (TK-Luc) construct was generated by removing the 
TRE triplet of pTRE-TK-Luc by digestion with BamHI and BglII followed by religation 
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and confirmation of the final construct by sequencing. The original plasmid backbone, 
pTRE-TK-Luc contains the thymidine kinase minimal promoter of the herpes simplex 
virus and was kindly provided by Dr. AM Zavacki (Boston, MA, USA). 
The TK-(dCpG)Luc was prepared using the TK-Luc plasmid backbone as follows. The 
pMOD Luc-ShS v02 plasmid (InvivoGen, San Diego, CA, USA) was used as a template 
to amplify the (dCpG)Luc coding region with Vent PCR (oligonucleotides: sense, 
catgcc ATGGAGGATGCCAAGAATATTAAGAA; antisense, ggaattc 
TTATTTGCCACCCTTCTTGGCCTTGATCA). The amplicon was cut with NcoI and 
inserted into the NcoI - and the blunted EcoNI sites of TK-Luc. The construct was 
confirmed by sequencing. 
The TK-NanoLuc was prepared by isolating the TRE lacking the minimal TK promoter 
from the pTRE-TK-Luc through digestion with BglII and HindIII and subsequent 
cloning of the released fragment into the corresponding sites of the pNL1.1 vector 
(Promega, Madison, WI, USA) followed by confirmation of the final construct by 
sequencing. 
The TK-Renilla-Luc was generated by truncating the 760 bp-long TK promoter of pRL-
TK (Promega) using BglII and EcoRI digestion followed by blunting with Klenow 
polymerase and subsequent religation. This resulted in a minimal TK promoter between 
EcoRI and HindIII that is 31 bp shorter than the 128 bp-long minimal TK promoter of 
TK-Luc. 3’ to the TK promoter, this construct also contains a 136 bp chimeric intron 
originating from pRL-TK. The construct was confirmed by restriction mapping. 
The constructs are shown in Figure 22. 
The mouse TRα (mTRα) expression construct was generated using the TRαCDM 
plasmid (Prost et al., 1998) (kindly provided by Dr. AM Zavacki, Boston, MA, USA) as 
a template to amplify mTRα coding region with Vent PCR (oligonucleotides sense: 
ggaattccat tATGGAACAG AAGCCAAGCA AGGT, antisense: ataagaatgc 
ggccgcTTAG ACTTCCTGAT CCTCAAAGA). The amplicon was cut with EcoRI and 
NotI and inserted into these sites of a pCI-Neo vector (Promega) and confirmed by 
sequencing. 
The secreted embryonic alkaline phosphatase (SEAP) encoding pSEAP2-Promoter 
plasmid (Clontech) was used for transfection control. 
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4.3. DNA transfections 
For studies on the post-transcriptional regulation of D2 HEK-293 cells were transfected 
with calcium phosphate precipitation as described earlier (Brent et al., 1989). 10 
micrograms of D10 based vector encoding the deiodinase was transiently transfected in 
the presence of 4 µg D15 helper vector required for the transcriptional activation of the 
promoter of D10 (Gossen and Bujard 1992). Results are given as the mean  SEM of 
D2 activities of duplicate plates of at least three separate experiments as the percentage 
of the cD2 control. 
For the investigation of the luciferase reporters, JEG-3 human choriocarcinoma cells 
(kindly provided by Dr. J. Szekeres, Pécs, Hungary) were cultured in 24-well plates in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS). When ~70% confluency was reached, cells were transfected with 800 ng 
DNA/well (including 200 ng Luciferase reporter, 100 ng mouse TRα, 10 ng pSEAP2 
and 490 ng pUC as inert DNA) using Lipofectamine® 2000 (Life 
Technologies/Thermo, Carlsbad, CA, USA). After ~6 hours the transfection media was 
replaced with DMEM containing 10% hormone-free fetal bovine serum (FBS) and 
incubated for 40 hours (Egri and Gereben, 2014). Briefly, 100 mg charcoal (Sigma, St. 
Louis, MO, USA) and 50 mg dextran (Sigma) were preincubated overnight in 0.01 
mol/l Tris buffer (pH=7.6). After centrifugation 40 ml FBS was added and incubated for 
1 hour. The suspension was recentrifugated and the supernatant was used to supplement 
DMEM. The media was replaced with DMEM with 10% hormone-free FBS containing 
either 50 nM 3,5,3’-triiodothyronine (+T3) or NaOH vehicle (-T3). After 24 hours, the 
culture media was collected for SEAP measurement (see Section 4.7.2). The cells were 
washed with phosphate buffered saline (PBS) and harvested in 100 µl Passive lysis 
buffer (Promega). 
 
4.4. RNA isolation and RT-PCR 
For the investigation of the ontogenic redistribution of D2, brain samples of E7, E8, E9, 
E10, E11, E13, and E15 chicken embryos were dissected in duplicates, and total RNA 
was isolated with Trizol (Life Technologies, Inc.). E13 and E15 brains were separated 
for telencephalon+diencephalon (A) and brainstem+cerebellum (B) parts. RNA was 
subjected to first strand cDNA synthesis using an oligonucleotide-dT primer and 
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amplified with D2-specific primers, as described earlier (Gereben et al., 2002). The cD2 
oligonucleotides were as follows (5’-3’): sense, CTG AAT TCA TCC GGC AGA AGA 
GAG; antisense, AGC TTC TCC TCC AAG TTT GA. The nonquantitative D2 
amplification was performed using the following program: 94 °C for 2 min; 35 cycles of 
94 °C for 30 sec, 58 °C for 30 sec, and 72 °C for 1 min; and then 72 °C for 4 min. 
For the studies on post-transcriptional regulation of D2 adult chicken telencephalons 
and livers were used. Total RNAs isolated from the telencephalon and liver were 
reverse transcribed using the antisense oligonucleotide CTCACCAGAA 
GGCCTGAAGA G and amplified by Taq polymerase (Sigma) by oligonucleotides, 
sense: CTGAATTCAT CCGGCAGAAG AGAG; antisense: AGCTTCTCCT 
CCAAGTTTGA. The amplicons generated on the brain cDNA were cloned into 
pGEM-T and subjected to automated sequencing. The amplifications were performed in 
two separate reactions. 
 
4.5. Northern blots 
The Northern blot for the ontogenic D2 distribution study was performed as previously 
described (Gereben et al., 1999). Briefly, total RNA was isolated with Trizol from the 
brains of E7, E8, E9, and E10 and hemispheres of E13, E15 and E17 chicken embryos 
as described in Section 4.4. A digoxigenin (DIG)-labelled single stranded cDNA probe 
complementer to 450 bp of the cD2 coding region was used to detect D2 in 30 µg of 
total RNA. The probe was labelled by linear PCR using the (5’-3’) 
TGCACAATGCACACTCGCTC antisense oligonucleotide and DIG-deoxyuridine 5-
triphosphate. As denominator for densitometry, the density of the 28S subunit of 
ethidium bromide stained gels was used. 
 
4.6. In situ hybridization 
The technique was used for the analysis of D2 mRNA ontogenic redistribution of the 
brains of E8 and E15 chicken embryos and 8-week-old chickens. The heads of three E8 
embryos and the brains of three E15 embryos and three 8-week-old chickens were 
quickly frozen on dry ice and stored at –80 C until used. Serial 12-µm-thick coronal 
sections were cut on cryostat, mounted on gelatine-coated slides, and dried at 42C 
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overnight. The sections were fixed with 4% paraformaldehyde in PBS (pH 7.4) for 30 
minutes washed in 2-fold concentration of standard sodium citrate (2X SSC), acetylated 
with 0.25% acetic anhydride in 0.9 % triethanolamine for 20 min; and then treated in 
graded solutions of ethanol (70, 80, 96, 100%), chloroform and a descending series of 
ethanol (100, 96%) for 5 minutes each and hybridized with an approximately 840 bp 
single-stranded DIG-11-uridine 5-triphosphate (Roche Diagnostics GmbH, Mannheim, 
Germany)-labelled cRNA probe for the entire coding region of cD2. The hybridizations 
were performed under plastic coverslips in a buffer containing 50% formamide, 2-fold 
concentration of standard sodium citrate, 10% dextran sulfate, 0.5% sodium dodecyl 
sulfate, 250 µg/ml denatured salmon sperm DNA, and the DIG-labelled probe, diluted 
at 1:100 for 16 h at 56C. The slides were washed in 1X SSC for 15 min and then 
treated with RNase (25 µg/ml) for 1 h, at 37C. After additional washes in 0.1X SSC (2 
X 30 min) at 65C, sections were washed in PBS and treated with the mixture of 0.5% 
Triton X-100 and 0.5% H2O2 for 15 min and then with 2% bovine serum albumin 
(BSA) in PBS for 20 min to reduce the nonspecific antibody binding. The sections were 
incubated with a mixture of sheep anti-DIG-alkaline phosphatase Fab fragments 
(1:1000, Roche Diagnostics) overnight at 4C. The alkaline phosphatase signal was 
detected using 5-bromo-4-chloro-3-indolyl-phosphate/4-nitroblue tetrazolium 
chromogen system (Roche Diagnostics) according to the manufacturer’s instructions. 
The reaction was developed for 6 hours, and then, the sections were rinsed in Tris buffer 
(pH 7.6). The sections were coverslipped using Aquatex mounting medium (Merck, 
Darmstadt Germany), and the images were taken with an Axiophot microscope (Carl 
Zeiss Inc, Göttingen, Germany) equipped with real-time spot digital camera (Diagnostic 
Instruments Inc., Sterling Heights, MI, USA). For semiquantitative analyses all samples 
were treated simultaneously. Three 20X field of the hypothalamus of each E15 and 
adult brain from three different anterior-posterior levels were analysed using ImageJ 
software (public domain from National Institutes of Health, USA). Background density 
points were removed by thresholding the image. The sum of integrated density values 
(density X area) was calculated for each animal. The specificity of hybridization was 
confirmed using a sense cD2 coding region probe, that resulted in the total absence of 
specific hybridization signal in the brain at all stages studied. 
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4.7. Assays 
4.7.1. Deiodinase assay 
For the investigation of the ontogenic redistribution of D2, brain samples of chicken 
embryos (E7, E8, E9, E10, E11, E13, and E15; n=5) were dissected and rapidly 
removed. The E13 and E15 brains were separated for telencephalon+diencephalon (A) 
and brainstem+cerebellum (B) parts. Samples were homogenized in ice-cold PE buffer 
[100 mM potassium phosphate, 1 mM ethylenediaminetetraacetic acid (EDTA) (pH 
6.9)] with 0.25M sucrose and 1 mM dithiothreitol (Gereben et al., 1999) and kept frozen 
at -80C until used. The assays contained approximately 150-600 µg homogenate 
proteins in 300 µl PE buffer [100 mM potassium phosphate, 1 mM EDTA (pH 6.9)] 
supplemented with various amounts of cold T4 (1 or 100 nM) and about 30,000 cpm of 
Sephadex LH-20 purified, labelled T4 and 20 mM DTT (Larsen et al., 1979). 
Measurements using 100 nM T4 were used to confirm the D2 nature of the measured 5’ 
deiodinase activity (Salvatore et al., 1996a). Additional incubations were performed 
with 1 nM T4 + 100 nM T3 + 1 mM 6-n propylthiouracil (PTU) added to the reaction 
buffer to inhibit D1 and D3 activity. Incubation was carried out at 37C for 2 hours. 
The amount of protein used for assays was set to keep the percent of deiodination 
between 5 and 30%. The reactions were stopped by adding 200 µl horse serum 
(Invitrogen, Carlsbad, CA, USA) and 100 µl of 50% trichloroacetic acid for 
precipitation (Berry et al., 1990). A fraction of supernatant (400 of 600 µl) was applied 
on ion exchange chromatography through self-made Dowex 50WX (Amersham 
Pharmacia Biosciences, Uppsala, Sweden) columns to further separate iodine from other 
thyroid hormone metabolites. The fraction of supernatant containing the iodine but not 
thyroid hormones was eluted with 2 ml of 10 % acetic acid and counted in a γ-counter 
(Wizard-1470, PerkinElmer Life and Analytical Sciences, Inc., Boston, MA, USA). 
Assays were carried out in duplicates at least twice, and the activity level was expressed 
in femtomoles released (Larsen et al., 1979) per hour per milligram of protein. Total 
count and background were calculated from several blank tubes containing no 
homogenate. The Δ77cD2 protein and the cD2 reporter based 5’UTR constructs were 
expressed in HEK-293 cells and assayed for D2 activity in the presence of 2 nM T4 
according to the method described earlier (Gereben et al., 1999). 
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4.7.2. Luciferase assay 
Luciferase activity was measured from 20 µl cell lysate with the Dual-luciferase 
Reporter Assay System (firefly luciferase for pTRE-TK-Luc, TK-Luc, TK-(dCpG)Luc; 
Renilla luciferase for TK-Renilla-Luc) as previously described (Zeold et al., 2006). 
Activity of the TK-NanoLuc was determined from 20 µl cell lysate with the Nano-Glo 
Luciferase Assay System (Promega) according to the manufacturer’s instructions. 
Luciferase activity of each transfected well was assayed separately. Measurements with 
the Dual-luciferase Reporter Assay System were performed in duplicates that were 
averaged to express luciferase activity of each well. Duplicates were closely agreeing 
with an average difference of 7%±1.62 and 5.9%±1.2 (mean±SEM; n=14) for –T3 and 
+T3 groups of pTRE-TK-Luc, respectively. All measurements were performed with a 
Luminoskan Ascent Luminometer (Thermo, Waltham, MA, USA). 
4.7.3. SEAP assay 
SEAP activity was determined from 25 µl media with Nova Bright™ SEAP Enzyme 
Reporter Gene Chemiluminescent Detection system 2.0 (Invitrogen/Thermo) as 
previously described (Egri and Gereben 2014). SEAP was used for normalization by 
calculating Firefly luciferase (Luc)/SEAP light unit or Renilla luciferase 
(Renilla)/SEAP light unit ratios for each well. Experiments were performed at least 
eight times and presented as mean ± SEM. 
 
4.8. Statistics 
Statistical analysis on deiodinase activity data were performed using one-way analysis 
of variance (ANOVA) followed by Newman-Keuls test. The sums of integrated density 
values of in situ hybridization reactions were compared by unpaired t test. 
Statistical analysis on luciferase assay data was performed with an unpaired two-
sample t-test using a 95% level of confidence. 
 
4.9. Sequences 
The sequence of the 77cD2 coding region was deposited into the GenBank under 
accession no. AF401753.  
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5. RESULTS 
5.1. Investigation of thyroid hormone availability in the developing chicken 
hypothalamus 
Our aims were to determine: 
 the expression of D2 mRNA in the brain of chicken embryos before and after 
the onset of the function of the thyroid gland 
 thyroid hormone activating capacity of the developing chicken brain reflected by 
the activity of the D2 enzyme 
 cell-type specific distribution of D2 mRNA expression in the brain of embryonic 
and adult chickens 
 
5.1.1. Assessment of D2 mRNA expression in the developing chicken brain using 
RT-PCR and Northern blot 
The D2 encoding mRNA transcript could be detected at all stages of the studied E7-E15 
period with RT-PCR using intron spanning oligonucleotides amplifying the coding 
region of the mRNA. The telencephalon-diencephalon could be separated from the 
brainstem-cerebellum in samples of E13 and E15 allowing the isolated analysis of these 
regions. The D2 transcript could be detected in all studied brain regions (Figure 11). 
The size of the PCR amplicon matched exactly the deducted size calculated from the 
clones of the wild-type cD2 transcript (GenBank AF125575, Gereben et al., 1999) 
indicating that no D2 mRNA splice variant was expressed in a detectable amount using 
a sensitive PCR-based approach during this period of brain development. 
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Figure 11. D2 mRNA expression in the developing chicken brain can be detected with RT-
PCR. The D2 mRNA was detected with RT-PCR at all stages studied. Only the wild type but 
not the spliced 77cD2 variant transcript (see Section 5.2.1) could be detected. In the negative 
control (neg. ctr.) amplification was performed in the absence of template by replacing the 
cDNA with water. E: embryonic day; A: Telencephalon + diencephalon; B: Brainstem + 
cerebellum, bp: base pairs. 
 
We then used Northern blot to quantify the amount of cD2 mRNA during chicken brain 
development from E7 to E17. A single transcript of expected size (~6 kb, GenBank 
AF125575) could be detected from E10 using a digoxigenin-labelled probe specific for 
the coding region of the cD2 mRNA (Figure 12). D2 expression underwent a robust 
increase during the studied period as represented by elevating D2/28 S density ratios 
(0.5, 2.1, 5.2, and 7.3 for E10, E13, E15 and E17, respectively) using density of 
ethidium bromide stained 28S ribosomal RNA fraction as denominator. 
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Figure 12. Ontogenic increase of D2 mRNA expression in the developing chicken brain. 
Northern blot using labelled cDNA probe was used to detect the D2 transcript. The lower panel 
demonstrates the ethidium bromide stained ribosomal RNA subunits as control for integrity and 
loading. The D2 mRNA was detected from E10 and increased robustly to stage E17. E: 
embryonic day, kb: kilobases 
 
5.1.2. D2 activity in the developing chicken brain (E7-E15) 
In order to gain a more direct insight into the TH activating capacity of the developing 
brain, we also measured the activity of the D2 enzyme. D2 activity could be detected 
from E7 (54 fmol/h/mg). From E13 a significant increase was found (p <0.001 by one 
way ANOVA followed by Newman Keuls posthoc-test) reaching a maximum of 148 
fmol/h/mg at E15 (Figure 12). In the E13 and E15 samples (where the 
telencephalon+diencephalon and brainstem+cerebellum samples could be measured 
separately), no significant difference was found between D2 activities. In order to 
confirm the D2-dependent nature of the measured 5’ deiodinase activity, we performed 
a fractional deiodination approach taking advantage from the highly different substrate 
sensitivity of types 1 and 2 deiodinases. Due to this highly different Km(T4), D2 activity 
can be suppressed by 100 nM T4 while this does not affect D1 enzyme activity. We 
found that only a very limited fraction of the measured 5’ deiodinase activity could be 
attributed to D1, since in the T4 saturation assay the deiodination of [125I]T4 by the 
DOI:10.14753/SE.2017.2032
 41 
 
brain homogenate was heavily suppressed at all investigated stages by the addition of 
100 nM cold T4 (Table 2). In addition, when 100 nM T3 and 1 mM PTU were added to 
the assays (to exclude D3 activity) deiodination was only moderately affected. The 
inhibition of 1 nM T4 outer ring deiodination was tested by adding 100 nM T3 and 1 
mM PTU and found to be slightly lower in E13-E15 samples compared to the E7-E8 (p 
< 0.01 by one way ANOVA followed by Newman-Keuls, Table 2). The activity was 
the highest in E13 and E15 samples (by one way ANOVA followed by Newman-Keuls, 
p < 0.01 when compared with E7 or E8). Thus the presented enzyme activity studies 
clearly confirmed the presence of authentic D2 activity in the brain of chicken embryos 
that increased during development. 
  
Figure 13. D2 activity in the brain of chicken embryos from E7 to E15. Specific low Km D2 
activity was present in the developing chicken brain from E7 to E15. Activity is expressed as 
femtomoles of iodine release /hour/mg protein. The increase of D2 activity was highly 
correlated with time during the whole investigated period (correlation coefficient 0.91, p < 
0.001). From stage E13 D2 activity was significantly higher, compared with the earliest tested 
period (one way ANOVA followed by Newman-Keuls, p < 0.001). The whole brains of E7, E8, 
E9, E10, and E11 embryos were used, whereas at E13 and E15, the brains were separated for 
telencephalon + diencephalon (A) and brainstem + cerebellum (B) parts. *, p < 0.001 vs. E7; **, 
p < 0.0001 vs. E7 by one way ANOVA followed by Newman-Keuls (mean ± SEM, n = 5). 
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Table 2. Fractional deiodination in the chicken embryonic brain 
 
Samples 
Fractional [
125
I]T4 deiodination relative to that  
at 1 nM concentration (%) 
100 nM T4 1 nM T4 + 100 nM T3 + 1 mM PTU 
E7 0 67.5 ± 6.7 
E8 0.5 ± 0.8 60.9 ± 2.4 
E9 1.8 ± 0.5 83.7 ± 6.8 
E10 0.7 ± 0.5 67.9 ± 2.5 
E11 3.4 ± 0.5 68.2 ± 1.4 
E13A 0.7 ± 0.2 72.4 ± 2.8 
E13B 3.1 ± 0.5 75.8 ± 3.4 
E15A 5.2 ± 0.7 80.8 ± 1.8 
E15B 5.1 ± 0.1 85.1 ± 1.5 
Fractional inhibition of [
125
I]T4 deiodination by different assay conditions. For the given sample, 
T4 deiodination at 1 nM concentration represents 100%. Assay conditions are shown above the 
columns. Data are given as mean ± SEM (n = 5). E, Day of incubation; A, telencephalon + 
diencephalon; B, brainstem + cerebellum. 
 
5.1.3. Distribution of D2 mRNA in the brain of developing chicken 
In order to study D2 expression at the cellular level, we used in situ hybridization to 
identify D2 mRNA in the developing brain. In the brain of E8 chicken embryos a rather 
weak D2 hybridization signal could be observed in scattered cell clusters (Figure 14A) 
using a digoxigenin-labelled probe specific for the D2 coding region. Signal intensity 
increased in perivascular like cell clusters throughout the brain of E15 embryos 
compared to the E8 stage (Figure 14B-D). No D2 hybridization signal was found in the 
ependymal cells lining the wall of the third ventricle (Figure 14B). 
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Figure 14. Distribution of D2 mRNA in the brain of E8 and E15 chicken embryos using in situ 
hybridization. The D2 hybridization signal is only very weak in the E8 brain sections (A). 
Arrows indicate modestly labelled cell clusters. The hybridization signal is markedly increased 
in the E15 brains (B–D). Low-magnification photomicrograph illustrates the D2 hybridization 
signal in the E15 hypothalamus (B). Arrowheads indicate the wall of the third ventricle. Note 
the lack of hybridization signal in the ependymal layer and the strong signal associated with 
elongated cell clusters (arrows). Strong hybridization signal in elongated cell clusters (arrows) 
in the E15 neostriatum (C) and hypothalamus (D). No signal was detected using a sense D2 
probe (E). Scale bar, 200 μm in A corresponds to A and B; scale bar, 100 μm in C corresponds 
to C–E. E8, E15: embryonic days 8 and 15.  
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5.1.4. Distribution of D2 mRNA in the brain of adult chicken 
In the adult chicken no hybridization signal could be observed in the wall of the rostral 
part of the third ventricle (Figure 15A) and the lateral ventricles. A subset of the 
ependymal cells lining the floor of the third ventricle at the rostral pole of the median 
eminence were positive for D2 (Figure 15B). However, in the more posterior segment, 
the D2-expressing cells covered the ventral one half to two-thirds of the ventricular wall 
(Figure 15C and D). The distribution pattern of the labelled ependymal cells was 
reminiscent of that of tanycytes. The D2 hybridization signal in other parts of the brain 
was in similar cell clusters as in the E15 brains but the intensity of hybridization signal 
was markedly decreased [E15 vs. adult (integrated density units) 15.90 ± 0.23 vs. 3.34 ± 
1.23, p = 0.0043] (compare Figure 15A-D and G with Figure 14). Strong D2 signal 
could be observed in isolated cells of the neostriatum (Figure 15E, F, and H). 
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Figure 15. Distribution of D2 mRNA in the brain of adult chicken. The density of D2 
hybridization signal associated with cell clusters is markedly decreased in the brain of adult 
chicken (A–H). A, No hybridization signal can be detected in the wall of the third ventricle 
rostral to the median eminence (arrowheads indicate the wall of the third ventricle, whereas 
arrows indicate modest signal in hypothalamic cell clusters). B, At the rostral pole of the 
median eminence, the hybridization signal was localized to the floor of the third ventricle 
(arrows). C, More caudally D2-expressing cells covered the ventral half of the ventricular wall 
(arrows). D, Higher-magnification micrograph illustrates the localization of D2 mRNA in the 
ependymal layer of the third ventricle (arrows). Arrows indicate examples for D2 hybridization 
signal in the adjacent hypothalamic tissue (open arrows). E, Low-magnification micrograph 
demonstrates the D2 hybridization signal in the cerebellum, hippocampus, and neostriatum 
caudale. F, Medium-power magnification of the same region is seen; arrows indicate D2 
hybridization signal in isolated cells. G, High-power image of an elongated cell cluster in the 
hypothalamus. H, The D2 hybridization signal is also present in isolated cells (arrows) in the 
neostriatum. Cb, Cerebellum; Hp, hippocampus; NC, neostriatum caudale; OC, optic chiasm. 
Scale bar, 400 μm in A corresponds to A–C and E; scale bar, 200 μm in D corresponds to D 
and F; scale bar 100 μm in G corresponds to G and H. 
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5.2. Understanding the RNA-dependent post-transcriptional regulation of the 
type 2 deiodinase (D2) encoding dio2 gene 
Our aim was to analyse the role of mRNA structure in the post-transcriptional 
regulation of D2 gene in thyroid hormone activation. Specifically, we studied the role of 
i) the alternative splicing and ii) the 5’UTR of the D2 mRNA in the regulation of D2 
activity. 
 
5.2.1. Cloning and characterization of an alternatively spliced chicken D2 
encoding transcript 
D2 mRNA levels and enzyme activity are discrepant in specific tissues which is 
strikingly represented by the finding that the same amount of a ~6.1 kb D2 mRNA 
species results in a 2.6-fold higher D2 activity in the brain than in the liver of chicken 
(408 vs. 156 fmol T4/h mg protein) (Gereben et al., 1999 and 2002). Therefore, we 
speculated whether post-transciptional events such as alternative splicing could play a 
role in the modulation of D2 activity. We hypothesized that a D2 mRNA species of 
slightly different size that would not appear on a routine screen could impact tissue-
specific D2 activity by encoding a D2 protein of altered activity. Therefore, we isolated 
D2 encoding mRNAs from the telencephalon and liver of adult chickens using RT-PCR. 
The amplified fragments were cloned into plasmids and subjected to sequencing. This 
approach allowed us to identify a cD2 mRNA containing a 77-bp deletion in the coding 
region in the proximity of the exon/intron junction of the D2 encoding dio2 gene 
(Figure 16A). The sequence of the novel cD2 splice variant was deposited into the 
GenBank under accession #AF401753. We subjected the 77cD2 encoding mRNA to 
experimental testing to determine its activity by inserting the spliced coding region into 
a D10 expression vector 5’ to SECIS element. The resulting construct was transiently 
transfected into HEK-293 cells. 77cD2 mRNA encoded an inactive D2 enzyme. The 
splicing-induced deletion resulted in the resetting of the reading frame of the cD2 
coding region. The deduced amino acid sequence of the 77cD2 protein indicated a 
truncated D2 protein that is terminated N-terminal to the active center (Figure 16B). 
DOI:10.14753/SE.2017.2032
 47 
 
 
 
Figure 16. Sequence analysis of the 77cD2 transcript. A, Alignment of the coding region of 
the chicken and human D2 coding regions (GenBank Acc. #AF125575 and U53506, 
respectively) to the sequence of the cD2. 77 bps (underlined) are missing from the cD2-clone#2. 
5’ and 3’ nucleotides of the spliced region are indicated in bold. A polymorphism of cD2-
clone#1 is shown in italics. The insertion site of the hdio2 intron is marked by an arrow, kbp: 
kilobase pair. B, Nucleic acid and deduced amino acid sequences of the alternatively spliced 
cD2 mRNA. The wild-type cD2 amino acid sequence is underlined and bold, the new junction 
is underlined and shown in bold italics. Numbers show positions in the cD2 mRNA GenBank 
Acc. #AF125575. 
  
A 
 
 
                 701                                                750 
cD2-AF125575     CACATGGTGC TGTTTCTGAG CCGCTCCAAG TCTGCGCGCG GCGAGTGGCG  
cD2-clone#1      CACATGGTGC TGTTTCTGAG CCGCTCCAAG TCTGCGCGCG GTGAGTGGCG  
cD2-clone#2      CACATGGTGC TGTTTCTGAG CCGCTCCAAG TCTGCGCGCG .......... 
hD2 coding       CACGTGGTGC TGCTGTTGAG CCGCTCCAAG TCCACTCGCG GAGAGTGGCG  
 
                 751                                                800 
cD2-AF125575     GAGGATGCTG ACCTCGGAGG GGCTGCGCTG CGTCTGGAAC AGCTTCCTCC  
cD2-clone#1      GAGGATGCTG ACCTCGGAGG GGCTGCGCTG CGTCTGGAAC AGCTTCCTCC  
cD2-clone#2      .......... .......... .......... .......... ..........  
hD2 coding       GCGCATGCTG ACCTCAGAGG GACTGCGCTG CGTCTGGAAG AGCTTCCTCC  
 
                 801                                     
cD2-AF125575     TGGACGCCTA CAAGCAGGTC AAACTTGGAG GAGA 
cD2-clone#1      TGGACGCCTA CAAGCAGGTC AAACTTGGAG GAGA 
cD2-clone#2      .......... .......GTC AAACTTGGAG GAGA  
hD2 coding       TCGATGCCTA CAAACAGGTG AAATTGGGTG AGGA 
   
 ~8 kbp hdio2 intron  
B 
 
 
    ATGGGTCTGTTAAGTGCGGATTTGCTGATCACGCTTCAGATCTTGCCGGTCTTTTTCTCC 
596 ----+---------+---------+---------+---------+---------+----- 655 
    M  G  L  L  S  A  D  L  L  I  T  L  Q  I  L  P  V  F  F  S   - 
 
 
    AATTGCCTCTTCCTTGCGCTGTATGACTCTGTGATCCTCCTGAAGCACATGGTGCTGTTT 
656 ----+---------+---------+---------+---------+---------+----- 715  
    N  C  L  F  L  A  L  Y  D  S  V  I  L  L  K  H  M  V  L  F   - 
 
 
    CTGAGCCGCTCCAAGTCTGCGCGCGGTCAAACTTGGAGGAGAAGCTCCGAACTCCAGTGT 
716 ----+---------+---------+---------+---------+---------+----- 775 
    L  S  R  S  K  S  A  R  G  Q  T  W  R  R  S  S  E  L  Q  C   - 
 
 
    AATCCACATAGCCAAGGGCAACGATGGCAGCAATAGCAGCTGGAAGAGTGTTGGT 
776 ----+---------+---------+---------+---------+---------+ 830 
    N  P  H  S  Q  G  Q  R  W  Q  Q  *                           - 
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Then we aimed to determine the expression of the 77cD2 mRNA in the liver and brain 
compared to the wild-type cD2 mRNA. We set up a PCR-based detection system that 
specifically amplified the spliced region to allow simultaneous detection of the wild-
type and spliced transcript in the same reaction. This approach can be used for 
semiquantitative detection of the wild-type and spliced amplicons due to their 
amplification by the same oligonucleotides in the same PCR (Figure 17). Using this 
system the coexpression of the wild-type and the 77cD2 mRNA could be confirmed in 
the telencephalon and liver of adult chicken. Compared to the wild-type, a higher 
amount of the splice variant could be detected in the liver, while this ratio was the 
opposite in the telencephalon (Figure 18). 
 
Figure 17. Schematic representation of the RT-PCR screening system allowing simultaneous 
detection of 77cD2 and wt cD2 mRNAs in chicken tissues. 
 
Figure 18. Expression of the 77cD2 transcript. Agarose gel electrophoresis of the PCR 
products from wild-type cD2 mRNA from telencephalon (T) and liver (L) from an adult chicken 
using oligos described in Section 4.2.1. The expected 277 bp band and a second ~200 bp 
product were generated. The products indicated by arrows were cloned and their sequences are 
shown in Figure 16A as cD2-clone#1 (wt) and cD2-clone#2 (77cD2). The positive control 
(pos. ctr.) clones were plasmids containing the wild-type (cD2wt) and spliced (77cD2) cD2 
coding regions. As a negative control (neg. ctr.) cDNA was replaced by water in the PCR. 
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5.2.2. Investigation of the functional role of the 5’UTR of chicken D2 mRNA 
The 5’UTR of the D2 mRNA is unusually long and we hypothesized that it could play a 
role in the regulation of D2 activity. We used a chicken D2-containing reporter to assess 
whether this mRNA region can modulate the activity of the D2 enzyme in HEK-293 
cells. The chicken D2 5’UTR exerted a robust suppressory effect on the activity of the 
cD2 enzyme by decreasing its activity by 5-fold (Figure 19). 
 
 
Figure 19. Effect of the chicken 5’UTR on D2 activity. The cD2 5’UTR was inserted 5’ to the 
cD2 reporter containing the cD2 coding region followed by the rat D1 minimal SECIS element. 
Plasmids were transiently transfected into HEK-293 cells as described in Section 4.3. Chicken 
D2 5’UTR decreased the activity of the cD2 enzyme by 5-fold. Data are the mean  SEM of 
relative D2 activities corrected for transfection efficiency of duplicate plates as a percentage of 
the activity of the cD2 reporter (n = 3; *, p< 0.001 vs. cD2 by t-test). 
 
We aimed to understand the molecular mechanism underlying this inhibitory effect. The 
D2 5’UTR contains sORFs, a feature shared by the known D2 5’UTR of different 
species. First we performed sequence analysis to determine which of the sORFs 
contains a -3 purine (A or G) representing the Kozak consensus sequence, a prerequisite 
of efficient translational initiation in eukaryotes. 
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Figure 20. The cD2 5’UTR contain sORFs. The presence of a strong translational initiation 
sequence (-3 purine base where position 1 is the A of the ATG start codon) is indicated by + 
(Kozak 1986). Unambiguous stop codons (UAA, UAG) and in frame UGAs followed by 
purines were considered as translational terminators. In-frame UGAs in possible readthrough 
position (codon followed by a pyrimidine base) are indicated by an asterisk (McCaughan et al., 
1995). Deduced amino acid sequences of the putative peptides are presented. 
 
Sequence analysis revealed that among the four sORFs of the chicken 5’ UTR only the 
second sORF from the direction of the transcriptional start site (cORF-B) met the set 
criterion (Figure 20). Therefore, we functionally tested the inhibitory potency of the 
isolated cORF-B on D2 activity using the abovementioned expression system in HEK-
293 cells. The cORF-B caused a 2.5-fold suppression in D2 activity. Importantly, a 
point-mutation evoked deletion of the ATG initiation codon completely abolished the 
cORF-B-dependent inhibition of D2 activity (Figure 21). This finding proved that 
translational initiation occurs at the cORF-B and as a consequence this mechanism is 
involved in the 5’UTR-dependent decrease in D2 activity. 
 
Figure 21. Role of cORF-B related translational initiation in the 5’UTR-dependent regulation 
of D2 activity. The cORF-B sequence was inserted into the cD2 reporter and transiently 
transfected into HEK-293 cells. The cORF-B caused a 2.5-fold suppression in D2 activity. ATG 
was mutated to TTG as shown in red. The point mutation completely abolished the cORF-B- 
dependent inhibition of D2 activity. Data are the mean  SEM of relative D2 activities of 
duplicate plates as a percentage of the activity of the cD2 reporter (n = 3; * p<0.05 vs. cORF-
B(Wt)-cD2 by unpaired t-test). 
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5.3. Identification of authentic reporter proteins for studies on T3-dependent 
gene transcription 
The T3-evoked promoter independent downregulation of firefly luciferase is a 
phenomenon that undermines studies on TH-dependent transcriptional regulation. Our 
aim was to find different luciferase reporters that are less susceptible to promoter 
independent T3-induced downregulation compared to the classical firefly luciferase. 
Mammalian expression constructs were generated containing the same minimal TK 
promoter as shown in Figure 22. This allowed to perform the experiments with the 
promoter type that proved to be unaffected by T3 treatment (Tillmann et al., 1993). In 
addition, this harmonized promoter design helped to eliminate differences in promoter-
dependent T3-response of different constructs. 
 
Figure 22. Schematic depiction of the generated mammalian expression constructs encoding 
different types of luciferase reporters driven by a minimal thymidine kinase (TK) promoter. The 
harboring plasmid backbone is indicated. The firefly luciferase cDNA of TK-Luc was replaced 
with the coding region of dCpG firefly luciferase. Thus, TK-Luc and TK-(dCpG)Luc are 
identical except for the regions encoding luciferase. 
 
As controls, we used JEG-3 cells transfected either with pTRE-TK-Luc or with TK-Luc 
firefly luciferase in the presence of co-transfected mTRα. The luciferase activity of the 
pTRE-TK-Luc was induced approximately 3-fold with 50 nM T3, while as expected, the 
same treatment suppressed luciferase activity of the no canonic TRE-containing TK-Luc 
reporter ~2.6-fold (Figure 23). We also tested the responsiveness of the SEAP construct 
used to monitor transfection efficiency. Importantly, T3 treatment did not affect the level 
of the SEAP internal control (SEAP level in pTRE-TK-Luc wells -T3: 0.97± 0.078 vs. 
+T3: 0.79±0.084) /mean±SEM; n=14, p=0.13 with t-test/; SEAP level in TK-Luc wells -
T3: 0.86±0.105 vs. +T3: 0.76±0.057 /mean±SEM; n=8, p=0.4 with t-test/). 
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Figure 23. Response of pTRE-TK-Luc and TK-Luc control firefly luciferase reporters to 50 nM 
T3 in JEG-3 cells. Reporters were co-transfected with mouse TRα. T3 induced the luciferase 
activity of the pTRE-TK-Luc around 3-fold (n = 14; p < 0.001). The activity of TK-Luc was 
suppressed by 2.6-fold (n = 8; p < 0.05). Results are expressed as firefly luciferase (Luc)/SEAP 
light unit ratios as mean  SEM. 
 
Using this characterized system, we tested the responsiveness of various luciferase 
reporters to T3 using the generated constructs that did not contain TRE in the canonical 
position 5’ to the promoter sequence. Notably, the TK-(dCpG)Luc encoding a synthetic 
firefly luciferase was not affected by the addition of 50 nM T3. The luciferase activity of 
the TK-NanoLuc showed a slight tendency of decreased activity, but it did not reach the 
level of statistical significance (Figure 24). On the other hand, T3 treatment 
significantly decreased (by approximately 30%) the activity of cultures expressing the 
TK-Renilla-Luc (Figure 24). 
 
 
Figure 24. Response of TK-(dCpG)Luc, TK-NanoLuc and TK-Renilla Luc luciferase reporters 
to 50 nM T3 in JEG-3 cells. Reporters were co-transfected with mouse TRα. T3 did not 
significantly affect luciferase activity encoded either by the TK-(dCpG)Luc (n = 28; p = 1) or 
TK-NanoLuc (n = 12; p = 0.27). T3 significantly reduced the activity of the TK-Renilla-Luc 
reporter (n = 11; p < 0.005). Results are expressed as firefly, Nano, or Renilla luciferase (Luc, 
NLuc, or Ren, respectively)/SEAP light unit ratios as mean  SEM. 
-T3                     +T3-T3                     +T3 -T3                     +T3
*
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Figure 25. Alignment of the 5’ 360 bp-long fragment of the coding region of firefly luciferase 
to the (dCpG) Luciferase. The DNA sequences of the full coding regions are only 77% identical 
(upper panel) but due to the silent nature of mutations they encode the same amino acid 
sequence (lower panel). 
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6. DISCUSSION 
6.1. Investigation of thyroid hormone availability in the developing chicken 
hypothalamus 
TH promotes cell differentiation during development by decreasing cyclin-D1 levels 
and inducing the expression of Nerve Growth Factor, thus consequently TH inhibits 
proliferation and promotes differentiation in the developing brain at the same time 
(Furumoto et al., 2005; Alvarez-Dolado et al., 1994). Therefore, the tight regulation of 
T3 levels is one of the events essential to keep cell proliferation and differentiation 
under strict control. We aimed to study how D2, the enzyme responsible for TH 
activation is expressed in different brain regions during chicken development. In 
contrast to rodents, chickens have a relatively well developed HPT axis at hatching 
which makes the kinetics of their axis development similar to that of humans (Taylor et 
al., 1990). TH is already present in the egg yolk as maternal hormone supply thus the 
substrate of the D2 enzyme is available (Prati et al., 1992). Furthermore, TRα is already 
expressed in the neural plate and tube well before the blastula stage that would allow 
TH action taken that activated TH is present (Forrest et al., 1991). 
Studies on the developmental regulation of TH availability in human embryos face 
ethical limitations. While no models are without shortcomings, still chickens provide a 
more useful approach with human relevance than rodents with respect to gain insight 
into the mechanisms regulating the TH economy in the developing brain. We addressed 
D2-mediated TH activation from different perspectives. RT-PCR was used to detect the 
presence of the D2 transcript in the developing chicken brain which allowed the 
detection of D2 expression from as early as E7. This was followed by Northern blot 
assisted quantification that revealed increasing D2 expession in the brain during 
ontogeny. The detected D2 mRNA encoded a functional enzyme as we demonstrated it 
by deiodinase assays. We also studied the fractional deiodination in the brain of chicken 
embryos to exclude the presence of D1 or D3 in the detected activity. The used 100 nM 
T4 saturation assay took advantage of the low Km nature of D2 activity. The finding that 
the overwhelming majority of 5’ deiodinase activity of the developing chicken brain 
was suppressed by 100 nM T4 demonstrated that the detected activity is authentic D2. 
We also performed PTU inhibition, a drug that inhibits D1 but not D2, while T3 excess 
was used to exclude D3 activity (Bianco et al., 2014). These results proved that D2 is 
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the predominant deiodinase enzyme in the developing chicken brain. The presence of 
D2 activity at early stages of chicken brain development is in accordance with findings 
that the cortex of the human fetus is able to perform D2-mediated TH activation already 
after 7-8 weeks of development (Chan et al., 2002). It was also demonstrated, that even 
in older chicken embryos (from E16 to hatching) D2 is the predominant activating 
deiodinase in the developing chicken brain (Van der Geyten et al., 2002).  
Our data indicating a fractional decrease of 100 nM T3 evoked suppression during the 
investigated period suggested that D3 activity decreased during development. This 
finding is in good agreement with previous data demonstrating lower D3 activity in the 
brain of hatched chickens compared to the second half of embryonic development 
(Reyns et al., 2003). More work need to be done to understand which factors can 
directly initiate D2 mRNA expression during brain development. It was recently 
suggested that Nkx2.1 could also play a role in this process (Mohácsik et al., 2016). Our 
Northern blot study indicated an increase in the D2 mRNA levels from E10. It should 
be noted that this approach is far less sensitive than PCR which clearly explains the 
difference between the appearance of D2 signals observed with the two distinct 
approaches. The appearance of the D2 signal in an amount detectable with Northern blot 
coincided with the onset of thyroidal secretion on E9.5 (Thommes et al., 1977) and it is 
in parallel with the period of intense glial cell proliferation (Rogers 1995). To better 
understand D2 expression at the cellular level during brain development, we used in situ 
hybridization in E8, E15 and adult chicken brains. D2 expression was found in 
elongated cell clusters with an appearance resembling perivascular cells. Since D2 is a 
glial enzyme (Mohácsik et al., 2011) we speculate that these D2 expressing cell clusters 
could be formed by perivascular astrocytes. D2 expression in this compartment 
increased from E8 and E15 that demonstrates with an independent approach that D2 
expression increases during brain development. Importantly, we did not observe the 
presence of the Δ77cD2 alternatively spliced D2 splice variant in the developing brain 
indicating that the entire amount of the expressed D2 mRNA is capable of encoding a 
functional D2 enzyme at these developmental stages. 
Remarkably, we observed D2 expression in the wall and the floor of the third ventricle 
of adult chickens in a distribution pattern reminiscent of tanycytes. Since D2 expression 
was earlier found in tanycytes of the rodent hypothalamus (Tu et al., 1997), our data 
DOI:10.14753/SE.2017.2032
 56 
 
indicated that D2 expression, which is phylogenetically conserved in this cell type, 
plays a crucial role in the regulation of the HPT axis. 
As already highlighted in Section 2, the onset of the negative feedback regulation of the 
HPT axis is poorly studied despite the fundamental impact of this phenomenon that 
persists throughout the entire lifespan. Interestingly, there is a gap between the onset of 
HPT feedback and the appearance of important factors of TH signalling. This suggests 
the need for a missing limiting factor. In chickens, the thyroid gland is functional from 
E9.5 while the anterior pituitary starts the stimulation of the secretion of the thyroid 
gland from E11.5 (Thommes et al., 1977). TRH is expressed well before the formation 
of the hypothalamus from E4.5 in the infundibulum and its level increases from E16 
during the embryonic development (Thommes et al., 1983; Geris et al., 1998). In 
addition, TRβ2 receptors required for TH action in the PVN can already be detected 
from E14 in the chicken brain (Grommen et al., 2008). Recently, TH injection studies in 
chicken embryos demonstrated that the onset of negative feedback evolves from E19 
until P2 in a D2-dependent manner (Mohácsik et al., 2016) suggesting that the intense, 
coordinated increase of D2 in the hypothalamus is the most important factor in the 
creation of the T3 gradient. Our data demonstrated that the increase of D2 activity, 
which builds up the T3 concentration required for hypothalamic feedback, starts already 
in the first half of embryonic development in chicken. On the other hand, D2 expression 
in tanycytes at embryonic stages did not exceed the detection level in our experiments 
that can be well explained by the lower sensitivity of a DIG-labelled cRNA probe 
compared to 35S-labelled probes. However, the question of the presence or absence of 
D2 expression in developing tanycytes between E8 and E15 is not a really relevant one 
in light of novel data demonstrating that not the tanycytic appearance of D2 but rather 
the increasing hypothalamic T3 gradient is the key factor in the onset of TH-mediated 
negative feedback (Mohácsik et al., 2016). 
In summary, we provided evidence that during brain development there is a profound 
ontogenically regulated increase in D2-mediated TH activation accompanied with 
ontogenic changes in the D2 mRNA expression. The developing chicken brain is able to 
generate T3 locally via D2 well before the onset of the thyroidal secretion. This 
challenges the dogma of minimized TH action in the proliferative developmental stages. 
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6.2. Understanding the RNA-dependent post-transcriptional regulation of the 
type 2 deiodinase (D2) encoding dio2 gene 
Typically, the increase of an mRNA results in increased level or higher activity of the 
encoded protein. In the case of the D2 enzyme this correlation is far less tight. While D2 
mRNA level and D2 activity increase in parallel by adrenergic mechanisms in the pineal 
gland or during its development (Tanaka et al., 1986; Kamiya et al., 1999; Campos-
Barros et al., 2000), in other tissues a remarkable complexity of D2 regulation can be 
observed manifested in discrepancies between the amount of D2 mRNA and D2 
enzyme activity. For example, the same amount of a ~6.1 kb D2 mRNA species results 
in 2.6-fold higher D2 activity in the brain than in the liver of chicken (408 vs. 156 fmol 
T4/h mg protein) (Gereben et al., 1999). This phenomenon also occurs under 
pathological conditions. D2 activity ratios reflecting activity in hyperfunctioning human 
thyroid adenomas vs. normal tissues is ~5-fold in contrast to the 3-fold ratio of D2 
mRNA expression of the two types of thyroid tissues (Murakami et al., 2001). 
Therefore, we speculated whether post-transciptional events such as alternative splicing, 
a process known to interfere with protein encoding capacity of a given D2 mRNA could 
play a role in the modulation of D2 activity. The D2 mRNA is unusually long, it is ~6-7 
kb in chicken and human, respectively (see Section 2.3). At least three types of mRNA 
transcripts differing by 500-700 nucleotides were detected in human thyroid, brain and 
other tissues (Croteau et al., 1996; Salvatore et al., 1996b; Bartha et al., 2000). 
However, the length of these mRNAs makes the identification of small changes quite 
difficult, despite their potential impact on the activity of the encoded protein. We 
speculated whether tissue-specific alteration in the ratio of D2 mRNA and activity could 
be underlain by the tissue-dependent presence of a D2 mRNA species which has a 
slightly different size and encodes an inactive D2 protein. We could identify a novel, 
alternatively spliced D2 transcript in the chicken brain and liver that encodes an inactive 
D2 protein. The mRNA encoding this inactive D2 protein lacks 77 nucleotides in the 
coding region. The deletion is adjacent to the conserved exon/intron junction of the D2 
encoding dio2 gene indicated by the finding that the 3’ end of the deleted region maps 
exactly to the exon/intron junction of the dio2 genes of human and mouse (Figure 16) 
(Bartha et al., 2000; Davey et al.; 1999; Song et al., 2000). Based on our PCR results, 
both the wild type and the Δ77cD2 transcripts are expressed in the chicken 
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telencephalon and liver. The different ratio of the two transcripts may account for the 
different D2 activity and mRNA ratios. 
Alternative transcripts were also detected in human tissue samples, e.g. in thyroid 
tissue. However, in this case instead of deletion of nucleotides the insertion of a 108 bp 
long intronic region could be observed after codon 74 (Gereben et al; 2002). In contrast 
to Δ77cD2, the reading frame remained unchanged in the hD2+108 human D2 
transcript. Interestingly, the derived hD2+108 protein is also inactive but this was 
achieved via a splicing mechanism different from the one generating the Δ77cD2 
mRNA. 
Other human D2 splice variants were also observed (GenBank Accession#AB041843) 
from a human cell line ECV304 (Ohba et al., 2001) and found to be present in the 
human brain, lung, kidney, heart and trachea. A truncated D2 coding region followed by 
the 3’UTR was also identified in a mouse cochlear cDNA library (GenBank AF177197) 
(Campos-Barros et al., 2000). In this case the divergence point was 35 bp 3’ to the 
conserved exon/intron junction. No details are known about the translation of this 
transcript. In the human thyroid an alternatively spliced intron of the 5’UTR of human 
D2 was described (Bartha et al., 2000). 
Our findings and the cited examples indicate that alternative splicing is an important 
mechanism to regulate the D2-mediated TH activation and tissue specific differences in 
the ratio of wild-type and spliced D2 transcript could affect D2 activity expressed by a 
specific amount of D2 mRNA. This phenomenon is phylogenetically conserved; it gives 
rise to differently spliced D2 mRNAs via different mechanisms. Further studies will be 
required to explore whether D2 alternative splicing can be regulated in an inducible 
manner or it is programmed to allow a tonic adjustment of D2 mRNA level in a given 
tissue. 
In addition to the alternative splicing of the D2 mRNA we also tested how its unusually 
long 5’UTR impacts activity of the D2 enzyme and demonstrated that this region of the 
D2 mRNA massively suppress D2 activity. We aimed to understand the mechanism 
underyling this suppressory effect therefore studied the role of sORFs embedded in the 
5’UTR region. 3-5 sORFs can be found in the 5’UTR of D2 mRNAs of different 
species including chicken, human, rat and mouse (Figure 20). In eukaryotes the 
presence of the Kozak consensus sequence is required to surround an ATG codon to 
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allow efficient translational initiation (see Section 2.7.2). We used this as a selection 
criterion to find sORF that can be potentially translated. Among chicken sORFs, only 
the second sORF (sORF-B) fulfilled this criterion, therefore, this was selected for 
functional studies. The sORF-B was able to cause a 2.5-fold decrease of D2 activity but 
only in the case when its initiator ATG was intact indicating that translational initiation 
occurs at the sORF-B. Thus the cORF-B in the 5’UTR serves as a translational 
roadblock to keep the translation of the D2-encoding reading frame low. This roadblock 
works via compromising ribosomal scanning of the D2 mRNA. Upon the small 40S 
ribosomal subunit reaches the initiator ATG of the sORF-B in the 5’UTR, it recruits the 
large 60S subunit to bind the complex and evoke the translational initiation. After 
translation of the sORF-B the ribosomal complex falls apart and only a limited number 
of 40S ribosomal subunits will be heading for further scanning of the more 3’ located 
reading frame encoding the D2 enzyme. The gain of this mechanism is manifested in 
the facilitation of tight regulation of the catalytically highly active D2 enzyme. While 
the sequence and the appearance of the sORF encoded peptide seems to be unrelevant 
for the cells, the initiation process itself plays an important role in D2 regulation. We 
can conclude that the D2 mRNA behaves in a functionally polycistronic manner. It is 
presently unknown whether 5’UTR based suppression of D2 activity can be modulated 
by specific factors or conditions. 
The 5’UTR and sORF based regulation is not unprecedented but uncommon and sORFs 
can be found only in 10% of the 5’UTR of vertebrate mRNAs (Kozak 1987). A few 
examples are represented by the Angiotensin II type IA receptor (Mori et al., 1996), the 
2 adrenergic receptor (Parola and Kobilka 1994) and HER-2 receptor (Child et al., 
1999). Among these the 5’UTR of the 2 adrenergic receptor is relatively well 
characterized and shows some similarity with D2 mRNA. Still, the sORF-based control 
is poorly understood in higher vertebrates. 5’UTR based translational control was also 
observed in yeasts and viruses (Hinnebusch 1994; Jackson and Kaminski 1995). It was 
also suggested that beyond sORFs other factors e.g. a secondary structure may also 
account for the translational inhibition (Kozak 1986). 
In summary, our results confirmed that the alternative splicing of the D2 mRNA and the 
sORF based translation inhibition of the 5’UTR control the activity of D2 enzyme. It 
also needs to be kept in mind that beyond the studied posttranscriptional events 
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important post-translational mechanisms are also involved in the complex regulation of 
D2 protein level and activity. Importantly, the substrate-induced ubiquitination of the 
enzyme leads to rapid proteasomal degradation by reducing the half-life of the D2 
protein (Gereben et al., 2000; Gereben et al., 2015). The multiplicity of regulatory 
mechanisms for D2 protein indicates that there is meticulous control of the deiodinative 
activation of T4 to T3. Therefore the correlation between D2 mRNA and activity is often 
weak and interpretation should be handled with care. 
 
6.3. Identification of authentic reporter proteins for studies on T3-dependent 
gene transcription 
TH can impact gene transcription both in a positive and negative manner (see Section 
2.6). While mechanism of T3-mediated positive regulation of gene expression is well 
understood, the mechanism of T3-mediated repression is more ambiguous and several 
molecular models exist to address this phenomenon. Studies on the effect of TH on a 
specific promoter are typically studied by luciferase reporters in transient expression 
systems. This is a fundamental approach to study the TH-mediated regulation of a 
specific gene. The assay is based on the fact that TH act predominantly via nuclear 
receptors and binding of T3 to TR can either activate or repress the transcription of the 
target gene. In reporter assays it is crucial that the reporter itself should not be affected 
by the factor to be studied. Importantly, it has been demonstrated that the firefly 
luciferase reporter protein is downregulated by T3 in a promoter and plasmid vector 
independent manner (Tillman et al., 1993; Maia et al., 1996). This phenomenon 
significantly undermines the accuracy of T3 dependent luciferase assays therefore we 
aimed to develop a working alternative to overcome this problem. 
It was revealed that T3-mediated downregulation of luciferase remained constant even 
in different vectors if the same thymidine kinase promoter fragment was used. Applying 
mutant receptors revealed that the suppressive effect of T3 was not observed if the DNA 
binding domain of the receptor was inactivated proving that the phenomenon is TR-
dependent. In parallel, usage of mutant promoters with modified TR binding sites also 
justified that the suppression remained. Simian virus (SV) promoters were also involved 
in the investigation but the negative effect after T3 addition remained unchanged. After 
further analysis of the effect of strong cis-linked positive TREs on the luciferase activity 
it was proven that only strong positive TREs are able to diminish the negative effect of 
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T3 and TR on the luciferase activity (Tillman et al., 1993). In other studies, the effect of 
unliganded thyroid hormone receptors on luciferase activity was tested in HEK-293, 
COS-7 and JEG-3 cells and while the phenomenon was not cell-line dependent, JEG-3 
cells proved to be the most sensitive to T3-mediated downregulation (Maia et al., 1996). 
It was concluded that a negative TRE should exist in the luciferase coding region. 
Similarly to Tillman’s group they also drew the conclusion that for studies on TH action 
the classical firefly luciferase does not provide an accurate reporter (Maia et al., 1996). 
The importance of this problem was also underlined by a cautionary note (Chan et al., 
2008) regarding the use of pBi-L dual expression plasmid for the generation of 
transgenic mice (Clontech) and the vector was also suggested to contain an unwanted 
and not identified negative TRE. This negative regulation could be observed only in the 
presence of TR and only in vectors that contained luciferase marker. This phenomenon 
did not show cell line-dependent features. It was suggested that each individual vector 
should be evaluated on a case by case basis before applying them in TH-related studies. 
The suitability of the pGL-2 reporter series (Promega) for transient T3-dependent 
expression studies was also questioned (Liu and Brent 2008) as the pGL-2 version 
contains numerous potential transcription sites. 
Since the luciferase reporter based assay is a widely used, convenient and extremely 
sensitive non-radioactive approach, we attempted to identifiy alternative luciferase 
reporters lacking the susceptibility of T3-mediated downregulation. Despite the well 
characterized positive TREs only very limited information is available regarding the 
negative TREs. Negative TRE was described in the TSHβ subunit (Shibusawa et al., 
2003), in the CD44 (Kim et al., 2005) and CYP7A1 genes (Drover et al., 2002), but 
these vary in DNA sequence, position and configuration thus computer-assisted 
prediction of negative TREs is not feasible based on sequence data. Therefore, we 
performed the experimental testing of the T3-responsiveness of various luciferase 
reporters. 
Previously, the herpes simplex TK minimal promoter was proven to be unaffected by T3 
(Tillmann et al., 1993) therefore we designed the constructs with the same minimal TK 
promoter. We used JEG-3 human choriocarcinoma cell line, as it was shown in former 
transient expression studies to be the most sensitive cell line for T3-mediated 
downregulation of the firefly luciferase gene (Maia et al., 1996). We set up controls by 
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using the pTRE-TK Luc that is upregulated after T3 treatment and TK-Luc where we 
removed the classical TRE and observed the expected up and downregulation after T3 
treatment, respectively. We used this controlled system to test the response of various 
luciferase proteins to T3. Testing of the dCpG luciferase revealed a complete resistance 
to T3-mediated downregulation. The dCpG luciferase is a codon-optimized modified 
luciferase reporter containing silent mutations that remove 95 2’-deoxyribo-cytidine-
phosphateguanosine (CpG) dinucleotides in a way that it is not reflected in its amino 
acid sequence. This way the dCpG luciferase coding region encodes the same amino 
acid sequence as the wild type firefly luciferase but the nucleotide sequence shows only 
77% homology. The resistance of the dCpG construct to the T3 treatment can be 
explained by the very likely disruption of the negative TRE(s) of the original sequence. 
We also tested a novel luciferase NanoLuc. NanoLuc was isolated from deep-sea 
shrimp Oplophorus gracilirostris and a synthetic form of the small unit of the luciferase 
was created (Hall et al., 2012). This new luciferase system has several advantages 
compared to the firefly and Renilla based reporters (see Section 2), it is more stable to 
environmental stress (like changes in pH, temperature) and the duration of the signal is 
longer. In our studies we found that only a slight and not significant reduction was 
observed after T3 treatment. Only a minimal decrease was observed, but it was within 
the range of the resolution limit of the assay. Our findings indicate that no potent 
negative TRE is present in the NanoLuc construct. To further widen the spectrum of the 
investigated constructs, Renilla reniformis luciferase was also tested (Lorenz et al., 
1991) which is widely used as internal control in luciferase assays. The T3 treatment 
caused a significant decrease in the luciferase expression compared to the control. 
However, the downregulation was less pronounced than in the case of the classical 
firefly but underlined that the popular Renilla luciferase reporter should be handled with 
care for T3-mediated promoter studies. 
In summary, we were able to identify alternative reporters, i.e the dCpG luciferase and 
the NanoLuc that can be more accurately used to assess TH responsiveness of a specific 
promoter than the classical firefly luciferase.  
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7. CONCLUSIONS 
We focused on the better understanding of the D2-mediated TH activation in the 
embryonic and adult chicken brain. D2 mRNA could be detected as early as on 
embryonic day 7, and the presence of activity of the D2 enzyme could also be readily 
detected. We provided evidence that D2 message can be detected from E8 in scattered 
cell clusters. This became stronger and localized in elongated perivascular like cell 
clusters in the neostriatum and hypothalamus of E15 embryos. The rearrangement of the 
D2-labelled cells could be observed in the investigated adult chicken brain samples, 
namely labelled ependymal cells reminiscent of tanycytes were detected in the wall of 
the third ventricle, while the intensity of hybridization signal in other parts of the brain 
was markedly decreased. All these results confirmed that the developing chicken brain 
is able to activate the prohormone thyroxine with D2 at a very early stage, well before 
the onset of the thyroidal secretion. The distribution pattern of D2 is subjected to change 
during brain development via ontogenic regulation and contributes to the adjustment of 
appropriate T3 levels in the central nervous system. Our findings challenge the dogma 
of minimized TH action during proliferative phases and calls to refine views on 
minimized T3 availability in the developing central nervous system. 
We confirmed the role of alternative splicing of the D2 mRNA in the post 
transcriptional regulation of the D2 encoding dio2 gene. We were able to identify and 
functionally test a novel alternatively spliced D2 mRNA in the brain and the liver of 
chickens. This transcript is 77 bp shorter than the wild-type D2 mRNA and encodes an 
inactive deiodinase enzyme. Our results indicate that alternative splicing is one of the 
several processing mechanisms that influence the level of D2 in a given tissue. Our 
results also confirm that D2 mRNA level quantification alone may be misleading in the 
interpretation of D2 enzyme activity levels of the different tissues. In addition, we 
demonstrated that the 5’UTR of the D2 mRNA down-regulates D2 activity and this 
effect is underlain by sORF based translation initiation. This mechanism helps to keep 
the translation of the D2 protein low which contributes to the tight regulation of this T3 
generating, highly active oxido-reductase. 
According to the current consensus, T3 exerts its biological effects predominantly via 
nuclear transcriptional events. Experimental assessment of this mechanism is a crucial 
approach to study thyroid hormone related signalling. T3-mediated regulation of the 
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classical firefly luciferase reporter is a significant set back of these studies. Therefore, 
our findings on the resistance of the dCpG luciferase and the NanoLuc to T3-mediated 
downregulation allow an accurate assessment of the potency of elements involved in the 
transcriptional regulation of TH-mediated gene expression in various reporter assays. 
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8. SUMMARY 
Thyroid hormones play an important role in the development and function of various 
organ systems. The hypothalamo-pituitary-thyroid axis is programmed to keep serum 
thyroid hormone level relatively stable, but at the tissue level thyroid hormone evoked 
changes are regulated by a tightly controlled local machinery. Our aim was to 
investigate the regulatory factors underlying thyroid hormone mediated effects using 
molecular and cell biological approaches. We addressed the regulation of thyroid 
hormone availability in the developing chicken hypothalamus; performed studies to 
better understand the RNA-dependent post-transcriptional regulation of the type 2 
deiodinase (D2) encoding dio2 gene; and also aimed to identify authentic luciferase 
reporter proteins for transcriptional studies on T3-dependent gene expression. 
We provided evidence that the D2 mRNA expression and activity can be detected from 
embryonic day 7 and encodes an active enzyme in the developing chicken brain. We 
also observed redistribution of cellular elements responsible for D2-mediated thyroid 
hormone activation in the ontogeny of the chicken brain. Our results prove that the local 
T3 generating machinery is functional already from early stages of development of the 
central nervous system that challenges the dogma of minimized TH action in the 
proliferative developmental stages. 
We identified two RNA-dependent post-transcriptional molecular mechanisms 
regulating D2 activity in chicken. We isolated an alternatively spliced D2 mRNA that 
encodes an inactive enzyme that could impact tissue specific D2 activity in the brain 
and liver of chicken. We also demonstrated that the 5’ untranslated region of D2 mRNA 
downregulates the activity of the D2 enzyme and the underlying molecular mechanism 
is based on short open reading frame associated translational initiation. 
We demonstrated that two novel luciferase reporters, the dCpG luciferase and the 
NanoLuc accurately measure the activity of T3-dependent gene expression in contrast to 
the classical firefly. The established approach allows the authentic assessment of 
transcriptional effects of thyroid hormone. 
Our studies contribute to the better understanding of cellular and molecular mechanisms 
underlying the effect of thyroid homone on the brain and other tissues. 
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9. ÖSSZEFOGLALÁS 
A pajzsmirigyhormonok fontos szerepet játszanak a különböző szervrendszerek 
fejlődésében és működésében. A hipotalamusz-hipofízis-pajzsmirigy tengely a szérum 
pajzsmirigyhormon szint viszonylagos stabilitásának fenntartására van programozva, 
azonban a szövetekben a pajzsmirigyhormonok által kiváltott változásokat szigorú 
szabályozás alatt álló helyi mechanizmusok irányítják. Célunk a pajzsmirigyhormon 
hatás szabályozó tényezőinek tanulmányozása volt, ehhez molekuláris és sejtbiológiai 
módszereket használtunk. Vizsgáltuk a fejlődő csirke hipotalamuszban a 
pajzsmirigyhormon elérhetőség szabályozását; kísérletet tettünk a kettes típusú dejodázt 
(D2) kódoló dio2 gén RNS-függő poszttranszkripcionális szabályozásának jobb 
megértésére; továbbá a T3-függő génexpresszió transzkripciós tanulmányozására 
alkalmas luciferáz riporter fehérjék azonosítását tűztük ki célul. 
Bizonyítottuk, hogy a D2 mRNS expressziója és enzimaktivitása már a 7. embrionális 
naptól kimutatható a fejlődő csirkeagyban. Megfigyeltük a D2 által kiváltott 
pajzsmirigyhormon aktiváció sejtes elemeinek újrarendeződését a csirke agyfejlődése 
folyamán. Eredményeink azt igazolják, hogy a T3 előállító rendszer már a központi 
idegrendszer korai fejlődési stádiumában működőképes, ami megkérdőjelezi azt az 
elképzelést, miszerint a pajzsmirigyhormon hatás minimalizálva van proliferatív 
fejlődési szakaszokban. 
Azonosítottunk két olyan RNS-függő, poszttranszkripcionális molekuláris 
mechanizmust, ami szerepet játszik a D2 aktivitás szabályozásában csirkében. 
Izoláltunk egy alternatívan hasított, inaktív enzimet kódoló D2 mRNS-t, ami szerepet 
játszhat a szövetspecifikus D2 aktivitás kialakulásában csirke agyban és májban. 
Kimutattuk továbbá, hogy a D2 mRNS 5’ nemtranszlálódó régiója csökkenti a D2 
enzim aktivitását és e folyamat molekuláris hátterében a rövid nyitott olvasási keret 
transzlációs iniciációja áll. 
Igazoltuk, hogy két új riporter, a dCpG és a NanoLuciferáz, a klasszikus “firefly” 
luciferázokkal ellentétben, pontosan méri a T3-függő génexpresszió aktivitását. A 
kidolgozott módszer lehetővé teszi a pajzsmirigyhormonok által kiváltott transzkripciós 
változások pontosabb megítélését. 
Vizsgálataink hozzájárulnak a pajzsmirigyhormonok agy- és egyéb szövetekben kifejtett 
hatásának hátterében álló sejtes és molekuláris folyamatok jobb megértéséhez.  
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